WO2005015158A2 - T1r hetero-oligomeric taste receptors, cell lines that express said receptors, and taste compounds - Google Patents
T1r hetero-oligomeric taste receptors, cell lines that express said receptors, and taste compounds Download PDFInfo
- Publication number
- WO2005015158A2 WO2005015158A2 PCT/US2004/025459 US2004025459W WO2005015158A2 WO 2005015158 A2 WO2005015158 A2 WO 2005015158A2 US 2004025459 W US2004025459 W US 2004025459W WO 2005015158 A2 WO2005015158 A2 WO 2005015158A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- compound
- receptor
- taste
- tir
- sweet
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 315
- 108020003175 receptors Proteins 0.000 title claims abstract description 155
- 235000019640 taste Nutrition 0.000 title claims description 105
- 108091005708 gustatory receptors Proteins 0.000 title abstract description 79
- 102100035942 Taste receptor type 1 member 3 Human genes 0.000 claims abstract description 196
- 101000659774 Homo sapiens Taste receptor type 1 member 3 Proteins 0.000 claims abstract description 190
- 102000005962 receptors Human genes 0.000 claims abstract description 154
- 102100035948 Taste receptor type 1 member 2 Human genes 0.000 claims abstract description 126
- 101000659765 Homo sapiens Taste receptor type 1 member 2 Proteins 0.000 claims abstract description 125
- 238000003556 assay Methods 0.000 claims abstract description 119
- 235000019583 umami taste Nutrition 0.000 claims abstract description 115
- 235000019605 sweet taste sensations Nutrition 0.000 claims abstract description 94
- 230000000694 effects Effects 0.000 claims abstract description 92
- 235000019607 umami taste sensations Nutrition 0.000 claims abstract description 81
- 101000659767 Homo sapiens Taste receptor type 1 member 1 Proteins 0.000 claims abstract description 49
- 102100035941 Taste receptor type 1 member 1 Human genes 0.000 claims abstract description 49
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 147
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 136
- 108090000623 proteins and genes Proteins 0.000 claims description 113
- 241000282414 Homo sapiens Species 0.000 claims description 99
- 102000004169 proteins and genes Human genes 0.000 claims description 94
- 238000000034 method Methods 0.000 claims description 90
- 235000018102 proteins Nutrition 0.000 claims description 90
- 235000009508 confectionery Nutrition 0.000 claims description 68
- 238000009739 binding Methods 0.000 claims description 67
- 230000027455 binding Effects 0.000 claims description 66
- 230000004044 response Effects 0.000 claims description 63
- 229940126601 medicinal product Drugs 0.000 claims description 61
- 230000003834 intracellular effect Effects 0.000 claims description 51
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims description 47
- 108091006027 G proteins Proteins 0.000 claims description 40
- 102000030782 GTP binding Human genes 0.000 claims description 40
- 108091000058 GTP-Binding Proteins 0.000 claims description 40
- -1 SC- 40014 Proteins 0.000 claims description 38
- 235000013923 monosodium glutamate Nutrition 0.000 claims description 38
- 229940109275 cyclamate Drugs 0.000 claims description 36
- 239000000796 flavoring agent Substances 0.000 claims description 35
- LPUQAYUQRXPFSQ-DFWYDOINSA-M monosodium L-glutamate Chemical class [Na+].[O-]C(=O)[C@@H](N)CCC(O)=O LPUQAYUQRXPFSQ-DFWYDOINSA-M 0.000 claims description 34
- 235000019634 flavors Nutrition 0.000 claims description 33
- 235000003599 food sweetener Nutrition 0.000 claims description 33
- 239000003765 sweetening agent Substances 0.000 claims description 33
- 239000004223 monosodium glutamate Chemical class 0.000 claims description 32
- SKORRGYRKQDXRS-UHFFFAOYSA-M sodium;2-(4-methoxyphenoxy)propanoate Chemical class [Na+].COC1=CC=C(OC(C)C([O-])=O)C=C1 SKORRGYRKQDXRS-UHFFFAOYSA-M 0.000 claims description 32
- GRSZFWQUAKGDAV-KQYNXXCUSA-N IMP Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(O)=O)O[C@H]1N1C(NC=NC2=O)=C2N=C1 GRSZFWQUAKGDAV-KQYNXXCUSA-N 0.000 claims description 31
- 229930006000 Sucrose Natural products 0.000 claims description 31
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 31
- 230000001965 increasing effect Effects 0.000 claims description 31
- 235000013902 inosinic acid Nutrition 0.000 claims description 31
- 239000005720 sucrose Substances 0.000 claims description 31
- 108010011485 Aspartame Proteins 0.000 claims description 30
- 235000005135 Micromeria juliana Nutrition 0.000 claims description 30
- 241000246354 Satureja Species 0.000 claims description 30
- 235000007315 Satureja hortensis Nutrition 0.000 claims description 30
- 239000000605 aspartame Substances 0.000 claims description 30
- 235000010357 aspartame Nutrition 0.000 claims description 30
- 229960003438 aspartame Drugs 0.000 claims description 30
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 claims description 29
- 229930195712 glutamate Natural products 0.000 claims description 28
- 101100315276 Homo sapiens TAS1R2 gene Proteins 0.000 claims description 26
- 229960002737 fructose Drugs 0.000 claims description 26
- 150000003839 salts Chemical class 0.000 claims description 26
- 239000011575 calcium Substances 0.000 claims description 24
- 229910052791 calcium Inorganic materials 0.000 claims description 24
- 108700010039 chimeric receptor Proteins 0.000 claims description 24
- 239000002243 precursor Substances 0.000 claims description 24
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 23
- 239000005715 Fructose Substances 0.000 claims description 23
- 229930091371 Fructose Natural products 0.000 claims description 22
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 22
- 101100315287 Homo sapiens TAS1R3 gene Proteins 0.000 claims description 21
- 230000001419 dependent effect Effects 0.000 claims description 18
- 239000004384 Neotame Substances 0.000 claims description 16
- 230000002401 inhibitory effect Effects 0.000 claims description 16
- 235000019412 neotame Nutrition 0.000 claims description 16
- HLIAVLHNDJUHFG-HOTGVXAUSA-N neotame Chemical compound CC(C)(C)CCN[C@@H](CC(O)=O)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 HLIAVLHNDJUHFG-HOTGVXAUSA-N 0.000 claims description 16
- 108010070257 neotame Proteins 0.000 claims description 16
- 230000002708 enhancing effect Effects 0.000 claims description 15
- ITVGXXMINPYUHD-CUVHLRMHSA-N neohesperidin dihydrochalcone Chemical compound C1=C(O)C(OC)=CC=C1CCC(=O)C(C(=C1)O)=C(O)C=C1O[C@H]1[C@H](O[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 ITVGXXMINPYUHD-CUVHLRMHSA-N 0.000 claims description 14
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 claims description 14
- 235000019204 saccharin Nutrition 0.000 claims description 14
- 229940081974 saccharin Drugs 0.000 claims description 14
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 claims description 14
- ZOOGRGPOEVQQDX-UUOKFMHZSA-N 3',5'-cyclic GMP Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=C(NC2=O)N)=C2N=C1 ZOOGRGPOEVQQDX-UUOKFMHZSA-N 0.000 claims description 13
- 239000008103 glucose Substances 0.000 claims description 13
- 229960001031 glucose Drugs 0.000 claims description 13
- RQFCJASXJCIDSX-UUOKFMHZSA-N guanosine 5'-monophosphate Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O RQFCJASXJCIDSX-UUOKFMHZSA-N 0.000 claims description 13
- 235000013928 guanylic acid Nutrition 0.000 claims description 13
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 12
- 239000004376 Sucralose Substances 0.000 claims description 12
- 235000019408 sucralose Nutrition 0.000 claims description 12
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 claims description 12
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 claims description 11
- 241000208713 Dionaea Species 0.000 claims description 11
- 229910001424 calcium ion Inorganic materials 0.000 claims description 11
- 235000010434 neohesperidine DC Nutrition 0.000 claims description 11
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 10
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 10
- QIVBCDIJIAJPQS-SECBINFHSA-N D-tryptophane Chemical compound C1=CC=C2C(C[C@@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-SECBINFHSA-N 0.000 claims description 10
- 235000018417 cysteine Nutrition 0.000 claims description 10
- 229960002920 sorbitol Drugs 0.000 claims description 10
- NUFKRGBSZPCGQB-FLBSXDLDSA-N (3s)-3-amino-4-oxo-4-[[(2r)-1-oxo-1-[(2,2,4,4-tetramethylthietan-3-yl)amino]propan-2-yl]amino]butanoic acid;pentahydrate Chemical class O.O.O.O.O.OC(=O)C[C@H](N)C(=O)N[C@H](C)C(=O)NC1C(C)(C)SC1(C)C.OC(=O)C[C@H](N)C(=O)N[C@H](C)C(=O)NC1C(C)(C)SC1(C)C NUFKRGBSZPCGQB-FLBSXDLDSA-N 0.000 claims description 9
- 239000004377 Alitame Chemical class 0.000 claims description 9
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 9
- 235000019409 alitame Nutrition 0.000 claims description 9
- 108010009985 alitame Chemical class 0.000 claims description 9
- 150000001720 carbohydrates Chemical class 0.000 claims description 9
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims description 9
- 230000008447 perception Effects 0.000 claims description 9
- 229960004793 sucrose Drugs 0.000 claims description 9
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 8
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 8
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 8
- 230000014860 sensory perception of taste Effects 0.000 claims description 8
- 239000000811 xylitol Substances 0.000 claims description 8
- 235000010447 xylitol Nutrition 0.000 claims description 8
- 229960002675 xylitol Drugs 0.000 claims description 8
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 8
- 239000004386 Erythritol Substances 0.000 claims description 7
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 claims description 7
- 125000000539 amino acid group Chemical group 0.000 claims description 7
- 230000007423 decrease Effects 0.000 claims description 7
- 235000019414 erythritol Nutrition 0.000 claims description 7
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 claims description 7
- 229940009714 erythritol Drugs 0.000 claims description 7
- 239000000600 sorbitol Substances 0.000 claims description 7
- 235000010356 sorbitol Nutrition 0.000 claims description 7
- XOFLBQFBSOEHOG-UUOKFMHZSA-N γS-GTP Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=S)[C@@H](O)[C@H]1O XOFLBQFBSOEHOG-UUOKFMHZSA-N 0.000 claims description 7
- WQZGKKKJIJFFOK-SVZMEOIVSA-N (+)-Galactose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-SVZMEOIVSA-N 0.000 claims description 6
- SERLAGPUMNYUCK-DCUALPFSSA-N 1-O-alpha-D-glucopyranosyl-D-mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-DCUALPFSSA-N 0.000 claims description 6
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical class [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 claims description 6
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 6
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 claims description 6
- 229930195725 Mannitol Natural products 0.000 claims description 6
- 239000000619 acesulfame-K Chemical class 0.000 claims description 6
- 229930003935 flavonoid Natural products 0.000 claims description 6
- 235000017173 flavonoids Nutrition 0.000 claims description 6
- 150000002215 flavonoids Chemical class 0.000 claims description 6
- 235000001727 glucose Nutrition 0.000 claims description 6
- 239000000905 isomalt Substances 0.000 claims description 6
- 235000010439 isomalt Nutrition 0.000 claims description 6
- HPIGCVXMBGOWTF-UHFFFAOYSA-N isomaltol Natural products CC(=O)C=1OC=CC=1O HPIGCVXMBGOWTF-UHFFFAOYSA-N 0.000 claims description 6
- 239000000832 lactitol Substances 0.000 claims description 6
- 235000010448 lactitol Nutrition 0.000 claims description 6
- VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 claims description 6
- 229960003451 lactitol Drugs 0.000 claims description 6
- 239000000594 mannitol Substances 0.000 claims description 6
- 235000010355 mannitol Nutrition 0.000 claims description 6
- 229960001855 mannitol Drugs 0.000 claims description 6
- 108050004114 Monellin Proteins 0.000 claims description 5
- 108700008625 Reporter Genes Proteins 0.000 claims description 5
- 230000030738 sensory perception of sweet taste Effects 0.000 claims description 5
- 230000030688 sensory perception of umami taste Effects 0.000 claims description 5
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 4
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 4
- 108060001084 Luciferase Proteins 0.000 claims description 4
- 239000005089 Luciferase Substances 0.000 claims description 4
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 4
- 235000010358 acesulfame potassium Nutrition 0.000 claims description 4
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 claims description 4
- 230000003247 decreasing effect Effects 0.000 claims description 4
- BJHIKXHVCXFQLS-UHFFFAOYSA-N 1,3,4,5,6-pentahydroxyhexan-2-one Chemical compound OCC(O)C(O)C(O)C(=O)CO BJHIKXHVCXFQLS-UHFFFAOYSA-N 0.000 claims description 3
- QBIFEYLZKPFJHE-ZDUSSCGKSA-N 2-[[(4-cyanoanilino)-[[(1s)-1-phenylethyl]amino]methylidene]amino]acetic acid Chemical compound N(/[C@@H](C)C=1C=CC=CC=1)=C(\NCC(O)=O)NC1=CC=C(C#N)C=C1 QBIFEYLZKPFJHE-ZDUSSCGKSA-N 0.000 claims description 3
- LKDRXBCSQODPBY-VRPWFDPXSA-N D-fructopyranose Chemical compound OCC1(O)OC[C@@H](O)[C@@H](O)[C@@H]1O LKDRXBCSQODPBY-VRPWFDPXSA-N 0.000 claims description 3
- GGLIEWRLXDLBBF-UHFFFAOYSA-N Dulcin Chemical compound CCOC1=CC=C(NC(N)=O)C=C1 GGLIEWRLXDLBBF-UHFFFAOYSA-N 0.000 claims description 3
- 239000004471 Glycine Substances 0.000 claims description 3
- XCOJIVIDDFTHGB-UEUZTHOGSA-N Perillartine Chemical compound CC(=C)[C@H]1CCC(\C=N\O)=CC1 XCOJIVIDDFTHGB-UEUZTHOGSA-N 0.000 claims description 3
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims description 3
- 102000008230 Toll-like receptor 3 Human genes 0.000 claims description 3
- 108010060885 Toll-like receptor 3 Proteins 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 3
- GZCGUPFRVQAUEE-SLPGGIOYSA-N aldehydo-D-glucose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O GZCGUPFRVQAUEE-SLPGGIOYSA-N 0.000 claims description 3
- 108010005774 beta-Galactosidase Proteins 0.000 claims description 3
- 239000008126 dulcin Substances 0.000 claims description 3
- NWNUTSZTAUGIGA-UHFFFAOYSA-N dulcin Natural products C12CC(C)(C)CCC2(C(=O)OC2C(C(O)C(O)C(COC3C(C(O)C(O)CO3)O)O2)O)C(O)CC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1OC1OC(CO)C(O)C(O)C1O NWNUTSZTAUGIGA-UHFFFAOYSA-N 0.000 claims description 3
- 229940013618 stevioside Drugs 0.000 claims description 3
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 claims description 3
- 235000019202 steviosides Nutrition 0.000 claims description 3
- 235000010436 thaumatin Nutrition 0.000 claims description 3
- 239000000892 thaumatin Substances 0.000 claims description 3
- 229930195727 α-lactose Natural products 0.000 claims description 3
- HCAJEUSONLESMK-UHFFFAOYSA-N cyclohexylsulfamic acid Chemical compound OS(=O)(=O)NC1CCCCC1 HCAJEUSONLESMK-UHFFFAOYSA-N 0.000 claims 8
- UDMBCSSLTHHNCD-UHFFFAOYSA-N Coenzym Q(11) Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(O)=O)C(O)C1O UDMBCSSLTHHNCD-UHFFFAOYSA-N 0.000 claims 2
- UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 claims 2
- LNQVTSROQXJCDD-UHFFFAOYSA-N adenosine monophosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(CO)C(OP(O)(O)=O)C1O LNQVTSROQXJCDD-UHFFFAOYSA-N 0.000 claims 2
- 102000005936 beta-Galactosidase Human genes 0.000 claims 1
- 239000012634 fragment Substances 0.000 abstract description 39
- 230000001939 inductive effect Effects 0.000 abstract description 8
- 238000000423 cell based assay Methods 0.000 abstract description 7
- 238000003384 imaging method Methods 0.000 abstract description 6
- 238000012188 high-throughput screening assay Methods 0.000 abstract description 4
- 101150065732 tir gene Proteins 0.000 description 305
- 210000004027 cell Anatomy 0.000 description 222
- 229920001184 polypeptide Polymers 0.000 description 127
- 150000007523 nucleic acids Chemical group 0.000 description 100
- 102000039446 nucleic acids Human genes 0.000 description 74
- 108020004707 nucleic acids Proteins 0.000 description 74
- 241000700159 Rattus Species 0.000 description 65
- 235000001014 amino acid Nutrition 0.000 description 60
- 230000014509 gene expression Effects 0.000 description 58
- 229940024606 amino acid Drugs 0.000 description 57
- 150000001413 amino acids Chemical class 0.000 description 56
- 239000003446 ligand Substances 0.000 description 53
- 102000003688 G-Protein-Coupled Receptors Human genes 0.000 description 49
- 108090000045 G-Protein-Coupled Receptors Proteins 0.000 description 49
- 239000000523 sample Substances 0.000 description 46
- 239000000203 mixture Substances 0.000 description 32
- 210000004899 c-terminal region Anatomy 0.000 description 31
- 108091052352 Tir receptor family Proteins 0.000 description 30
- 231100000673 dose–response relationship Toxicity 0.000 description 29
- 238000003018 immunoassay Methods 0.000 description 28
- UDIPTWFVPPPURJ-UHFFFAOYSA-M Cyclamate Chemical compound [Na+].[O-]S(=O)(=O)NC1CCCCC1 UDIPTWFVPPPURJ-UHFFFAOYSA-M 0.000 description 27
- 230000006870 function Effects 0.000 description 26
- 238000000338 in vitro Methods 0.000 description 25
- 239000000126 substance Substances 0.000 description 25
- 125000003275 alpha amino acid group Chemical group 0.000 description 24
- 238000009396 hybridization Methods 0.000 description 24
- 241001465754 Metazoa Species 0.000 description 22
- 239000000556 agonist Substances 0.000 description 21
- 238000013518 transcription Methods 0.000 description 21
- 239000003623 enhancer Substances 0.000 description 20
- 238000012360 testing method Methods 0.000 description 20
- 230000035897 transcription Effects 0.000 description 20
- 238000001514 detection method Methods 0.000 description 19
- 239000007787 solid Substances 0.000 description 19
- 238000006467 substitution reaction Methods 0.000 description 19
- 210000001519 tissue Anatomy 0.000 description 19
- 239000000047 product Substances 0.000 description 18
- 108091028043 Nucleic acid sequence Proteins 0.000 description 17
- MMWCIQZXVOZEGG-HOZKJCLWSA-N [(1S,2R,3S,4S,5R,6S)-2,3,5-trihydroxy-4,6-diphosphonooxycyclohexyl] dihydrogen phosphate Chemical compound O[C@H]1[C@@H](O)[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](O)[C@H]1OP(O)(O)=O MMWCIQZXVOZEGG-HOZKJCLWSA-N 0.000 description 17
- 239000000427 antigen Substances 0.000 description 17
- 108091007433 antigens Proteins 0.000 description 17
- 102000036639 antigens Human genes 0.000 description 17
- 235000013305 food Nutrition 0.000 description 17
- 230000010287 polarization Effects 0.000 description 17
- 239000013615 primer Substances 0.000 description 17
- 238000010361 transduction Methods 0.000 description 17
- 230000026683 transduction Effects 0.000 description 17
- 239000011230 binding agent Substances 0.000 description 16
- 239000012528 membrane Substances 0.000 description 16
- 239000000758 substrate Substances 0.000 description 16
- 239000013598 vector Substances 0.000 description 16
- 108020004414 DNA Proteins 0.000 description 15
- 210000004379 membrane Anatomy 0.000 description 15
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 14
- 230000004913 activation Effects 0.000 description 14
- 238000003199 nucleic acid amplification method Methods 0.000 description 14
- 230000005945 translocation Effects 0.000 description 14
- 230000003321 amplification Effects 0.000 description 13
- 239000005557 antagonist Substances 0.000 description 13
- 235000013361 beverage Nutrition 0.000 description 13
- 210000000170 cell membrane Anatomy 0.000 description 13
- 239000003153 chemical reaction reagent Substances 0.000 description 13
- 108020001507 fusion proteins Proteins 0.000 description 13
- 102000037865 fusion proteins Human genes 0.000 description 13
- 239000003112 inhibitor Substances 0.000 description 13
- 108020001756 ligand binding domains Proteins 0.000 description 13
- 239000002773 nucleotide Substances 0.000 description 13
- 125000003729 nucleotide group Chemical group 0.000 description 13
- 241000894007 species Species 0.000 description 13
- 108700028369 Alleles Proteins 0.000 description 12
- 229930195714 L-glutamate Natural products 0.000 description 12
- 108020004705 Codon Proteins 0.000 description 11
- 239000012190 activator Substances 0.000 description 11
- 239000002585 base Substances 0.000 description 11
- 230000001086 cytosolic effect Effects 0.000 description 11
- 239000013604 expression vector Substances 0.000 description 11
- 230000003993 interaction Effects 0.000 description 11
- 150000002500 ions Chemical class 0.000 description 11
- 102000004190 Enzymes Human genes 0.000 description 10
- 108090000790 Enzymes Proteins 0.000 description 10
- 102000016193 Metabotropic glutamate receptors Human genes 0.000 description 10
- 108010010914 Metabotropic glutamate receptors Proteins 0.000 description 10
- 241000699666 Mus <mouse, genus> Species 0.000 description 10
- 238000004458 analytical method Methods 0.000 description 10
- 239000003795 chemical substances by application Substances 0.000 description 10
- 239000002299 complementary DNA Substances 0.000 description 10
- 230000000875 corresponding effect Effects 0.000 description 10
- 230000002163 immunogen Effects 0.000 description 10
- 230000019491 signal transduction Effects 0.000 description 10
- 108091035707 Consensus sequence Proteins 0.000 description 9
- 239000001329 FEMA 3811 Substances 0.000 description 9
- 108091034117 Oligonucleotide Proteins 0.000 description 9
- 238000001727 in vivo Methods 0.000 description 9
- 238000002372 labelling Methods 0.000 description 9
- 230000001404 mediated effect Effects 0.000 description 9
- 230000003278 mimic effect Effects 0.000 description 9
- 229940089953 neohesperidin dihydrochalcone Drugs 0.000 description 9
- 238000002360 preparation method Methods 0.000 description 9
- 108010050543 Calcium-Sensing Receptors Proteins 0.000 description 8
- 102100035650 Extracellular calcium-sensing receptor Human genes 0.000 description 8
- 150000001408 amides Chemical class 0.000 description 8
- 230000000295 complement effect Effects 0.000 description 8
- 239000000975 dye Substances 0.000 description 8
- 238000002875 fluorescence polarization Methods 0.000 description 8
- 230000005764 inhibitory process Effects 0.000 description 8
- 238000000159 protein binding assay Methods 0.000 description 8
- 238000000746 purification Methods 0.000 description 8
- 210000003370 receptor cell Anatomy 0.000 description 8
- 239000007790 solid phase Substances 0.000 description 8
- 230000009870 specific binding Effects 0.000 description 8
- 230000009261 transgenic effect Effects 0.000 description 8
- 229930182827 D-tryptophan Natural products 0.000 description 7
- 238000007792 addition Methods 0.000 description 7
- 230000000890 antigenic effect Effects 0.000 description 7
- 235000020958 biotin Nutrition 0.000 description 7
- 229960002685 biotin Drugs 0.000 description 7
- 239000011616 biotin Substances 0.000 description 7
- 230000008859 change Effects 0.000 description 7
- 230000000723 chemosensory effect Effects 0.000 description 7
- 230000004186 co-expression Effects 0.000 description 7
- 238000012875 competitive assay Methods 0.000 description 7
- 239000004615 ingredient Substances 0.000 description 7
- 238000000670 ligand binding assay Methods 0.000 description 7
- 125000005647 linker group Chemical group 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- 230000003389 potentiating effect Effects 0.000 description 7
- 238000012216 screening Methods 0.000 description 7
- 235000014347 soups Nutrition 0.000 description 7
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 6
- 108060003951 Immunoglobulin Proteins 0.000 description 6
- 108020004711 Nucleic Acid Probes Proteins 0.000 description 6
- 241000283984 Rodentia Species 0.000 description 6
- 235000014633 carbohydrates Nutrition 0.000 description 6
- 238000010168 coupling process Methods 0.000 description 6
- 238000005859 coupling reaction Methods 0.000 description 6
- 230000009260 cross reactivity Effects 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 6
- 210000003527 eukaryotic cell Anatomy 0.000 description 6
- 230000004907 flux Effects 0.000 description 6
- 102000018358 immunoglobulin Human genes 0.000 description 6
- 239000003607 modifier Substances 0.000 description 6
- 239000002853 nucleic acid probe Substances 0.000 description 6
- 229920000642 polymer Polymers 0.000 description 6
- 235000015067 sauces Nutrition 0.000 description 6
- 238000010561 standard procedure Methods 0.000 description 6
- 238000003786 synthesis reaction Methods 0.000 description 6
- 238000002965 ELISA Methods 0.000 description 5
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 5
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 5
- 241000699670 Mus sp. Species 0.000 description 5
- 108091005461 Nucleic proteins Proteins 0.000 description 5
- 108010090804 Streptavidin Proteins 0.000 description 5
- 102000014384 Type C Phospholipases Human genes 0.000 description 5
- 108010079194 Type C Phospholipases Proteins 0.000 description 5
- 238000013459 approach Methods 0.000 description 5
- 235000021311 artificial sweeteners Nutrition 0.000 description 5
- 238000010256 biochemical assay Methods 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 239000000872 buffer Substances 0.000 description 5
- 230000001413 cellular effect Effects 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 5
- 230000001900 immune effect Effects 0.000 description 5
- 210000004962 mammalian cell Anatomy 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 235000012054 meals Nutrition 0.000 description 5
- 230000035772 mutation Effects 0.000 description 5
- 108091033319 polynucleotide Proteins 0.000 description 5
- 102000040430 polynucleotide Human genes 0.000 description 5
- 239000002157 polynucleotide Substances 0.000 description 5
- 239000013641 positive control Substances 0.000 description 5
- 238000012552 review Methods 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 230000000638 stimulation Effects 0.000 description 5
- 230000002103 transcriptional effect Effects 0.000 description 5
- 229960004799 tryptophan Drugs 0.000 description 5
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 4
- 241000251468 Actinopterygii Species 0.000 description 4
- 108091026890 Coding region Proteins 0.000 description 4
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 4
- 108091006099 G alpha subunit Proteins 0.000 description 4
- 102000034353 G alpha subunit Human genes 0.000 description 4
- 241000238631 Hexapoda Species 0.000 description 4
- 125000003412 L-alanyl group Chemical group [H]N([H])[C@@](C([H])([H])[H])(C(=O)[*])[H] 0.000 description 4
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 4
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 4
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 4
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 4
- 241000124008 Mammalia Species 0.000 description 4
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 4
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 4
- 239000008122 artificial sweetener Substances 0.000 description 4
- 238000002820 assay format Methods 0.000 description 4
- 239000011324 bead Substances 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 238000003776 cleavage reaction Methods 0.000 description 4
- 230000008878 coupling Effects 0.000 description 4
- 239000013078 crystal Substances 0.000 description 4
- 230000005284 excitation Effects 0.000 description 4
- 238000000799 fluorescence microscopy Methods 0.000 description 4
- 239000007850 fluorescent dye Substances 0.000 description 4
- 230000002068 genetic effect Effects 0.000 description 4
- 239000005556 hormone Substances 0.000 description 4
- 229940088597 hormone Drugs 0.000 description 4
- 239000001257 hydrogen Substances 0.000 description 4
- 229910052739 hydrogen Inorganic materials 0.000 description 4
- 238000000099 in vitro assay Methods 0.000 description 4
- 238000011534 incubation Methods 0.000 description 4
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 4
- 239000000816 peptidomimetic Substances 0.000 description 4
- 238000003259 recombinant expression Methods 0.000 description 4
- 238000003757 reverse transcription PCR Methods 0.000 description 4
- 239000002336 ribonucleotide Substances 0.000 description 4
- 230000007017 scission Effects 0.000 description 4
- 238000002864 sequence alignment Methods 0.000 description 4
- 235000000346 sugar Nutrition 0.000 description 4
- 238000013519 translation Methods 0.000 description 4
- 230000014616 translation Effects 0.000 description 4
- OZFAFGSSMRRTDW-UHFFFAOYSA-N (2,4-dichlorophenyl) benzenesulfonate Chemical compound ClC1=CC(Cl)=CC=C1OS(=O)(=O)C1=CC=CC=C1 OZFAFGSSMRRTDW-UHFFFAOYSA-N 0.000 description 3
- WXTMDXOMEHJXQO-UHFFFAOYSA-N 2,5-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC(O)=CC=C1O WXTMDXOMEHJXQO-UHFFFAOYSA-N 0.000 description 3
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 3
- 239000012591 Dulbecco’s Phosphate Buffered Saline Substances 0.000 description 3
- 108010013369 Enteropeptidase Proteins 0.000 description 3
- 102100029727 Enteropeptidase Human genes 0.000 description 3
- 108700024394 Exon Proteins 0.000 description 3
- OUVXYXNWSVIOSJ-UHFFFAOYSA-N Fluo-4 Chemical compound CC1=CC=C(N(CC(O)=O)CC(O)=O)C(OCCOC=2C(=CC=C(C=2)C2=C3C=C(F)C(=O)C=C3OC3=CC(O)=C(F)C=C32)N(CC(O)=O)CC(O)=O)=C1 OUVXYXNWSVIOSJ-UHFFFAOYSA-N 0.000 description 3
- 101710093473 Gurmarin Proteins 0.000 description 3
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 3
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 3
- 125000002707 L-tryptophyl group Chemical group [H]C1=C([H])C([H])=C2C(C([C@](N([H])[H])(C(=O)[*])[H])([H])[H])=C([H])N([H])C2=C1[H] 0.000 description 3
- 108010006519 Molecular Chaperones Proteins 0.000 description 3
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 3
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 3
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Chemical compound CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 235000004279 alanine Nutrition 0.000 description 3
- 230000001476 alcoholic effect Effects 0.000 description 3
- 230000000692 anti-sense effect Effects 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 238000004422 calculation algorithm Methods 0.000 description 3
- 235000013877 carbamide Nutrition 0.000 description 3
- 230000009137 competitive binding Effects 0.000 description 3
- 125000004122 cyclic group Chemical group 0.000 description 3
- 210000000805 cytoplasm Anatomy 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000002255 enzymatic effect Effects 0.000 description 3
- 230000004927 fusion Effects 0.000 description 3
- 125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 description 3
- 238000012203 high throughput assay Methods 0.000 description 3
- 230000000984 immunochemical effect Effects 0.000 description 3
- 230000001976 improved effect Effects 0.000 description 3
- 238000007901 in situ hybridization Methods 0.000 description 3
- 238000003780 insertion Methods 0.000 description 3
- 230000037431 insertion Effects 0.000 description 3
- 239000002502 liposome Substances 0.000 description 3
- 108020004999 messenger RNA Proteins 0.000 description 3
- 108010038422 metabotropic glutamate receptor 4 Proteins 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 230000036963 noncompetitive effect Effects 0.000 description 3
- 230000009871 nonspecific binding Effects 0.000 description 3
- 238000007899 nucleic acid hybridization Methods 0.000 description 3
- 230000036961 partial effect Effects 0.000 description 3
- 150000003905 phosphatidylinositols Chemical class 0.000 description 3
- 230000026731 phosphorylation Effects 0.000 description 3
- 238000006366 phosphorylation reaction Methods 0.000 description 3
- 230000002285 radioactive effect Effects 0.000 description 3
- 230000010076 replication Effects 0.000 description 3
- 230000008685 targeting Effects 0.000 description 3
- 238000001890 transfection Methods 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 3
- 150000003672 ureas Chemical class 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- JWZZKOKVBUJMES-UHFFFAOYSA-N (+-)-Isoprenaline Chemical compound CC(C)NCC(O)C1=CC=C(O)C(O)=C1 JWZZKOKVBUJMES-UHFFFAOYSA-N 0.000 description 2
- 102100039705 Beta-2 adrenergic receptor Human genes 0.000 description 2
- 102100026189 Beta-galactosidase Human genes 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 108090000204 Dipeptidase 1 Proteins 0.000 description 2
- 239000004097 EU approved flavor enhancer Substances 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 2
- OHCQJHSOBUTRHG-KGGHGJDLSA-N FORSKOLIN Chemical compound O=C([C@@]12O)C[C@](C)(C=C)O[C@]1(C)[C@@H](OC(=O)C)[C@@H](O)[C@@H]1[C@]2(C)[C@@H](O)CCC1(C)C OHCQJHSOBUTRHG-KGGHGJDLSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 2
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- HAEJPQIATWHALX-KQYNXXCUSA-N ITP Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O[C@H]1N1C(N=CNC2=O)=C2N=C1 HAEJPQIATWHALX-KQYNXXCUSA-N 0.000 description 2
- 108010058683 Immobilized Proteins Proteins 0.000 description 2
- 102000009786 Immunoglobulin Constant Regions Human genes 0.000 description 2
- 108010009817 Immunoglobulin Constant Regions Proteins 0.000 description 2
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 2
- 108700005091 Immunoglobulin Genes Proteins 0.000 description 2
- 102000004310 Ion Channels Human genes 0.000 description 2
- 150000008575 L-amino acids Chemical class 0.000 description 2
- 125000000415 L-cysteinyl group Chemical group O=C([*])[C@@](N([H])[H])([H])C([H])([H])S[H] 0.000 description 2
- 125000003338 L-glutaminyl group Chemical group O=C([*])[C@](N([H])[H])([H])C([H])([H])C([H])([H])C(=O)N([H])[H] 0.000 description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 2
- 240000008415 Lactuca sativa Species 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- 102100038354 Metabotropic glutamate receptor 4 Human genes 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- 238000000636 Northern blotting Methods 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- 102000012547 Olfactory receptors Human genes 0.000 description 2
- 108050002069 Olfactory receptors Proteins 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- YIKSCQDJHCMVMK-UHFFFAOYSA-N Oxamide Chemical class NC(=O)C(N)=O YIKSCQDJHCMVMK-UHFFFAOYSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- 102000035195 Peptidases Human genes 0.000 description 2
- 108010067902 Peptide Library Proteins 0.000 description 2
- 108091093037 Peptide nucleic acid Proteins 0.000 description 2
- 108091000080 Phosphotransferase Proteins 0.000 description 2
- 241000276498 Pollachius virens Species 0.000 description 2
- 108010066717 Q beta Replicase Proteins 0.000 description 2
- 108091028664 Ribonucleotide Proteins 0.000 description 2
- 238000012300 Sequence Analysis Methods 0.000 description 2
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 241001441723 Takifugu Species 0.000 description 2
- 101710120037 Toxin CcdB Proteins 0.000 description 2
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 2
- 150000003926 acrylamides Chemical class 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 102000030621 adenylate cyclase Human genes 0.000 description 2
- 108060000200 adenylate cyclase Proteins 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 125000006295 amino methylene group Chemical group [H]N(*)C([H])([H])* 0.000 description 2
- 238000003491 array Methods 0.000 description 2
- 108010014499 beta-2 Adrenergic Receptors Proteins 0.000 description 2
- 102000006635 beta-lactamase Human genes 0.000 description 2
- 238000010170 biological method Methods 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 229920001222 biopolymer Polymers 0.000 description 2
- 235000019658 bitter taste Nutrition 0.000 description 2
- 229930189065 blasticidin Natural products 0.000 description 2
- 229940098773 bovine serum albumin Drugs 0.000 description 2
- 235000010633 broth Nutrition 0.000 description 2
- 229940077731 carbohydrate nutrients Drugs 0.000 description 2
- 230000036978 cell physiology Effects 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 230000002925 chemical effect Effects 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 235000008504 concentrate Nutrition 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 235000013409 condiments Nutrition 0.000 description 2
- 230000021615 conjugation Effects 0.000 description 2
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 2
- 238000012217 deletion Methods 0.000 description 2
- 230000037430 deletion Effects 0.000 description 2
- 239000005547 deoxyribonucleotide Substances 0.000 description 2
- 230000030609 dephosphorylation Effects 0.000 description 2
- 238000006209 dephosphorylation reaction Methods 0.000 description 2
- 238000000586 desensitisation Methods 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000010494 dissociation reaction Methods 0.000 description 2
- 230000005593 dissociations Effects 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 239000012636 effector Substances 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 210000002409 epiglottis Anatomy 0.000 description 2
- 210000003238 esophagus Anatomy 0.000 description 2
- 230000005281 excited state Effects 0.000 description 2
- 235000013373 food additive Nutrition 0.000 description 2
- 239000002778 food additive Substances 0.000 description 2
- 235000013355 food flavoring agent Nutrition 0.000 description 2
- 235000019264 food flavour enhancer Nutrition 0.000 description 2
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 235000013922 glutamic acid Nutrition 0.000 description 2
- 239000004220 glutamic acid Substances 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 239000005090 green fluorescent protein Substances 0.000 description 2
- 125000000487 histidyl group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 description 2
- 238000002744 homologous recombination Methods 0.000 description 2
- 230000006801 homologous recombination Effects 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 230000003053 immunization Effects 0.000 description 2
- 238000005462 in vivo assay Methods 0.000 description 2
- 229960000367 inositol Drugs 0.000 description 2
- 230000031146 intracellular signal transduction Effects 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 229940039009 isoproterenol Drugs 0.000 description 2
- 238000011005 laboratory method Methods 0.000 description 2
- 150000002605 large molecules Chemical class 0.000 description 2
- 238000007834 ligase chain reaction Methods 0.000 description 2
- 229920002521 macromolecule Polymers 0.000 description 2
- 229960002160 maltose Drugs 0.000 description 2
- 238000013507 mapping Methods 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 230000035800 maturation Effects 0.000 description 2
- 229930182817 methionine Natural products 0.000 description 2
- 238000010369 molecular cloning Methods 0.000 description 2
- 239000003068 molecular probe Substances 0.000 description 2
- 235000021096 natural sweeteners Nutrition 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 210000002569 neuron Anatomy 0.000 description 2
- 238000007826 nucleic acid assay Methods 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- 210000000287 oocyte Anatomy 0.000 description 2
- 210000003254 palate Anatomy 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 235000021317 phosphate Nutrition 0.000 description 2
- 102000020233 phosphotransferase Human genes 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 230000035479 physiological effects, processes and functions Effects 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 235000008476 powdered milk Nutrition 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 210000001236 prokaryotic cell Anatomy 0.000 description 2
- 238000003127 radioimmunoassay Methods 0.000 description 2
- 230000009257 reactivity Effects 0.000 description 2
- 239000000018 receptor agonist Substances 0.000 description 2
- 229940044601 receptor agonist Drugs 0.000 description 2
- 230000027425 release of sequestered calcium ion into cytosol Effects 0.000 description 2
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 2
- 235000012045 salad Nutrition 0.000 description 2
- 235000014438 salad dressings Nutrition 0.000 description 2
- 238000003345 scintillation counting Methods 0.000 description 2
- 238000002821 scintillation proximity assay Methods 0.000 description 2
- 230000003248 secreting effect Effects 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 235000019613 sensory perceptions of taste Nutrition 0.000 description 2
- 102000034285 signal transducing proteins Human genes 0.000 description 2
- 108091006024 signal transducing proteins Proteins 0.000 description 2
- 150000003384 small molecules Chemical class 0.000 description 2
- 229910001415 sodium ion Inorganic materials 0.000 description 2
- 238000003746 solid phase reaction Methods 0.000 description 2
- 238000010671 solid-state reaction Methods 0.000 description 2
- 150000003431 steroids Chemical class 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 210000001779 taste bud Anatomy 0.000 description 2
- 230000035923 taste sensation Effects 0.000 description 2
- 238000004809 thin layer chromatography Methods 0.000 description 2
- 150000003568 thioethers Chemical class 0.000 description 2
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 108700012359 toxins Proteins 0.000 description 2
- 230000014621 translational initiation Effects 0.000 description 2
- 150000003673 urethanes Chemical class 0.000 description 2
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 description 1
- MIEKOFWWHVOKQX-UHFFFAOYSA-N (S)-2-(4-Methoxyphenoxy)propanoic acid Chemical compound COC1=CC=C(OC(C)C(O)=O)C=C1 MIEKOFWWHVOKQX-UHFFFAOYSA-N 0.000 description 1
- BDNKZNFMNDZQMI-UHFFFAOYSA-N 1,3-diisopropylcarbodiimide Chemical compound CC(C)N=C=NC(C)C BDNKZNFMNDZQMI-UHFFFAOYSA-N 0.000 description 1
- NCYCYZXNIZJOKI-IOUUIBBYSA-N 11-cis-retinal Chemical compound O=C/C=C(\C)/C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-IOUUIBBYSA-N 0.000 description 1
- VGONTNSXDCQUGY-RRKCRQDMSA-N 2'-deoxyinosine Chemical group C1[C@H](O)[C@@H](CO)O[C@H]1N1C(N=CNC2=O)=C2N=C1 VGONTNSXDCQUGY-RRKCRQDMSA-N 0.000 description 1
- NHBKXEKEPDILRR-UHFFFAOYSA-N 2,3-bis(butanoylsulfanyl)propyl butanoate Chemical compound CCCC(=O)OCC(SC(=O)CCC)CSC(=O)CCC NHBKXEKEPDILRR-UHFFFAOYSA-N 0.000 description 1
- KGLPWQKSKUVKMJ-UHFFFAOYSA-N 2,3-dihydrophthalazine-1,4-dione Chemical class C1=CC=C2C(=O)NNC(=O)C2=C1 KGLPWQKSKUVKMJ-UHFFFAOYSA-N 0.000 description 1
- 150000003923 2,5-pyrrolediones Chemical class 0.000 description 1
- ZBMRKNMTMPPMMK-UHFFFAOYSA-N 2-amino-4-[hydroxy(methyl)phosphoryl]butanoic acid;azane Chemical compound [NH4+].CP(O)(=O)CCC(N)C([O-])=O ZBMRKNMTMPPMMK-UHFFFAOYSA-N 0.000 description 1
- JRYMOPZHXMVHTA-DAGMQNCNSA-N 2-amino-7-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1h-pyrrolo[2,3-d]pyrimidin-4-one Chemical compound C1=CC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O JRYMOPZHXMVHTA-DAGMQNCNSA-N 0.000 description 1
- QWTBDIBOOIAZEF-UHFFFAOYSA-N 3-[chloro-[di(propan-2-yl)amino]phosphanyl]oxypropanenitrile Chemical compound CC(C)N(C(C)C)P(Cl)OCCC#N QWTBDIBOOIAZEF-UHFFFAOYSA-N 0.000 description 1
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- CJIJXIFQYOPWTF-UHFFFAOYSA-N 7-hydroxycoumarin Natural products O1C(=O)C=CC2=CC(O)=CC=C21 CJIJXIFQYOPWTF-UHFFFAOYSA-N 0.000 description 1
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- HJCMDXDYPOUFDY-WHFBIAKZSA-N Ala-Gln Chemical compound C[C@H](N)C(=O)N[C@H](C(O)=O)CCC(N)=O HJCMDXDYPOUFDY-WHFBIAKZSA-N 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 108090000328 Arrestin Proteins 0.000 description 1
- 102000003916 Arrestin Human genes 0.000 description 1
- 108010074613 Arrestins Proteins 0.000 description 1
- 102000008081 Arrestins Human genes 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 108090001008 Avidin Proteins 0.000 description 1
- 239000010755 BS 2869 Class G Substances 0.000 description 1
- 101710125089 Bindin Proteins 0.000 description 1
- 101001086405 Bos taurus Rhodopsin Proteins 0.000 description 1
- 241000208199 Buxus sempervirens Species 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- 102000017926 CHRM2 Human genes 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 102000014914 Carrier Proteins Human genes 0.000 description 1
- 108010078791 Carrier Proteins Proteins 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 102000009410 Chemokine receptor Human genes 0.000 description 1
- 108050000299 Chemokine receptor Proteins 0.000 description 1
- 108010035563 Chloramphenicol O-acetyltransferase Proteins 0.000 description 1
- 101150012960 Chrm2 gene Proteins 0.000 description 1
- 108020004635 Complementary DNA Proteins 0.000 description 1
- 235000003363 Cornus mas Nutrition 0.000 description 1
- 240000006766 Cornus mas Species 0.000 description 1
- 241001137251 Corvidae Species 0.000 description 1
- IGXWBGJHJZYPQS-SSDOTTSWSA-N D-Luciferin Chemical compound OC(=O)[C@H]1CSC(C=2SC3=CC=C(O)C=C3N=2)=N1 IGXWBGJHJZYPQS-SSDOTTSWSA-N 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 239000003155 DNA primer Substances 0.000 description 1
- 230000004568 DNA-binding Effects 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
- CYCGRDQQIOGCKX-UHFFFAOYSA-N Dehydro-luciferin Natural products OC(=O)C1=CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 CYCGRDQQIOGCKX-UHFFFAOYSA-N 0.000 description 1
- SUZLHDUTVMZSEV-UHFFFAOYSA-N Deoxycoleonol Natural products C12C(=O)CC(C)(C=C)OC2(C)C(OC(=O)C)C(O)C2C1(C)C(O)CCC2(C)C SUZLHDUTVMZSEV-UHFFFAOYSA-N 0.000 description 1
- SHIBSTMRCDJXLN-UHFFFAOYSA-N Digoxigenin Natural products C1CC(C2C(C3(C)CCC(O)CC3CC2)CC2O)(O)C2(C)C1C1=CC(=O)OC1 SHIBSTMRCDJXLN-UHFFFAOYSA-N 0.000 description 1
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 1
- 108010016626 Dipeptides Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 108050001049 Extracellular proteins Proteins 0.000 description 1
- 108010074860 Factor Xa Proteins 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- BJGNCJDXODQBOB-UHFFFAOYSA-N Fivefly Luciferin Natural products OC(=O)C1CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 BJGNCJDXODQBOB-UHFFFAOYSA-N 0.000 description 1
- 102000004437 G-Protein-Coupled Receptor Kinase 1 Human genes 0.000 description 1
- 108091004242 G-Protein-Coupled Receptor Kinase 1 Proteins 0.000 description 1
- 102000027583 GPCRs class C Human genes 0.000 description 1
- 108091008882 GPCRs class C Proteins 0.000 description 1
- 102000018899 Glutamate Receptors Human genes 0.000 description 1
- 108010027915 Glutamate Receptors Proteins 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 108010031186 Glycoside Hydrolases Proteins 0.000 description 1
- 102000005744 Glycoside Hydrolases Human genes 0.000 description 1
- 241000208253 Gymnema sylvestre Species 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 229920000209 Hexadimethrine bromide Polymers 0.000 description 1
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 1
- 241000701044 Human gammaherpesvirus 4 Species 0.000 description 1
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical class NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 1
- 102000004157 Hydrolases Human genes 0.000 description 1
- 108090000604 Hydrolases Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
- 108010067060 Immunoglobulin Variable Region Proteins 0.000 description 1
- 229930010555 Inosine Natural products 0.000 description 1
- UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 1
- 125000000570 L-alpha-aspartyl group Chemical group [H]OC(=O)C([H])([H])[C@]([H])(N([H])[H])C(*)=O 0.000 description 1
- 125000002059 L-arginyl group Chemical group O=C([*])[C@](N([H])[H])([H])C([H])([H])C([H])([H])C([H])([H])N([H])C(=N[H])N([H])[H] 0.000 description 1
- 125000000010 L-asparaginyl group Chemical group O=C([*])[C@](N([H])[H])([H])C([H])([H])C(=O)N([H])[H] 0.000 description 1
- 125000002061 L-isoleucyl group Chemical group [H]N([H])[C@]([H])(C(=O)[*])[C@](C([H])([H])[H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 125000003440 L-leucyl group Chemical group O=C([*])[C@](N([H])[H])([H])C([H])([H])C(C([H])([H])[H])([H])C([H])([H])[H] 0.000 description 1
- 125000001176 L-lysyl group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C([H])([H])C([H])([H])C([H])([H])C(N([H])[H])([H])[H] 0.000 description 1
- 125000000393 L-methionino group Chemical group [H]OC(=O)[C@@]([H])(N([H])[*])C([H])([H])C(SC([H])([H])[H])([H])[H] 0.000 description 1
- 125000002435 L-phenylalanyl group Chemical group O=C([*])[C@](N([H])[H])([H])C([H])([H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 125000002842 L-seryl group Chemical group O=C([*])[C@](N([H])[H])([H])C([H])([H])O[H] 0.000 description 1
- 125000000769 L-threonyl group Chemical group [H]N([H])[C@]([H])(C(=O)[*])[C@](O[H])(C([H])([H])[H])[H] 0.000 description 1
- 125000003798 L-tyrosyl group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C([H])([H])C1=C([H])C([H])=C(O[H])C([H])=C1[H] 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 125000003580 L-valyl group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(C([H])([H])[H])(C([H])([H])[H])[H] 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 108090001090 Lectins Proteins 0.000 description 1
- 102000004856 Lectins Human genes 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- DDWFXDSYGUXRAY-UHFFFAOYSA-N Luciferin Natural products CCc1c(C)c(CC2NC(=O)C(=C2C=C)C)[nH]c1Cc3[nH]c4C(=C5/NC(CC(=O)O)C(C)C5CC(=O)O)CC(=O)c4c3C DDWFXDSYGUXRAY-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 101710175625 Maltose/maltodextrin-binding periplasmic protein Proteins 0.000 description 1
- 108010052285 Membrane Proteins Proteins 0.000 description 1
- 108010065028 Metabotropic Glutamate 5 Receptor Proteins 0.000 description 1
- 102100038357 Metabotropic glutamate receptor 5 Human genes 0.000 description 1
- 241000699660 Mus musculus Species 0.000 description 1
- 101000860173 Myxococcus xanthus C-factor Proteins 0.000 description 1
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical class ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 1
- 229930193140 Neomycin Natural products 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 108700020796 Oncogene Proteins 0.000 description 1
- 102000043276 Oncogene Human genes 0.000 description 1
- 102000016979 Other receptors Human genes 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 108010043958 Peptoids Proteins 0.000 description 1
- 108700020962 Peroxidase Proteins 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 108700019535 Phosphoprotein Phosphatases Proteins 0.000 description 1
- 102000004861 Phosphoric Diester Hydrolases Human genes 0.000 description 1
- 108090001050 Phosphoric Diester Hydrolases Proteins 0.000 description 1
- 206010035226 Plasma cell myeloma Diseases 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 229920002873 Polyethylenimine Polymers 0.000 description 1
- 239000004642 Polyimide Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 229920002396 Polyurea Polymers 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241001415846 Procellariidae Species 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102000016971 Proto-Oncogene Proteins c-kit Human genes 0.000 description 1
- 108010014608 Proto-Oncogene Proteins c-kit Proteins 0.000 description 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
- 108090000244 Rat Proteins Proteins 0.000 description 1
- 101000844718 Rattus norvegicus Deleted in malignant brain tumors 1 protein Proteins 0.000 description 1
- 101001032838 Rattus norvegicus Metabotropic glutamate receptor 5 Proteins 0.000 description 1
- 102100040756 Rhodopsin Human genes 0.000 description 1
- 108090000820 Rhodopsin Proteins 0.000 description 1
- 108090000799 Rhodopsin kinases Proteins 0.000 description 1
- 108010083644 Ribonucleases Proteins 0.000 description 1
- 102000006382 Ribonucleases Human genes 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 102000003800 Selectins Human genes 0.000 description 1
- 108090000184 Selectins Proteins 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 108090000787 Subtilisin Proteins 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical class OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 1
- 102000002933 Thioredoxin Human genes 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- AUYYCJSJGJYCDS-LBPRGKRZSA-N Thyrolar Chemical class IC1=CC(C[C@H](N)C(O)=O)=CC(I)=C1OC1=CC=C(O)C(I)=C1 AUYYCJSJGJYCDS-LBPRGKRZSA-N 0.000 description 1
- 108091023040 Transcription factor Proteins 0.000 description 1
- 102000040945 Transcription factor Human genes 0.000 description 1
- 108010087042 Transducin Proteins 0.000 description 1
- 102000006612 Transducin Human genes 0.000 description 1
- 102000004338 Transferrin Human genes 0.000 description 1
- 108090000901 Transferrin Proteins 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- 108070000030 Viral receptors Proteins 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 238000001261 affinity purification Methods 0.000 description 1
- 238000007818 agglutination assay Methods 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 229940093740 amino acid and derivative Drugs 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 230000009830 antibody antigen interaction Effects 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 238000003149 assay kit Methods 0.000 description 1
- 238000000376 autoradiography Methods 0.000 description 1
- 210000003050 axon Anatomy 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 235000021168 barbecue Nutrition 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 125000005605 benzo group Chemical group 0.000 description 1
- 102000011262 beta-Adrenergic Receptor Kinases Human genes 0.000 description 1
- 108010037997 beta-Adrenergic Receptor Kinases Proteins 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 230000001588 bifunctional effect Effects 0.000 description 1
- 239000003012 bilayer membrane Substances 0.000 description 1
- 238000004166 bioassay Methods 0.000 description 1
- 238000012742 biochemical analysis Methods 0.000 description 1
- 238000002306 biochemical method Methods 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 238000006664 bond formation reaction Methods 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 235000021152 breakfast Nutrition 0.000 description 1
- 238000013262 cAMP assay Methods 0.000 description 1
- 235000012970 cakes Nutrition 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 230000003185 calcium uptake Effects 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 101150039352 can gene Proteins 0.000 description 1
- 235000013574 canned fruits Nutrition 0.000 description 1
- 125000001314 canonical amino-acid group Chemical group 0.000 description 1
- 238000005251 capillar electrophoresis Methods 0.000 description 1
- 210000000234 capsid Anatomy 0.000 description 1
- AIXAANGOTKPUOY-UHFFFAOYSA-N carbachol Chemical compound [Cl-].C[N+](C)(C)CCOC(N)=O AIXAANGOTKPUOY-UHFFFAOYSA-N 0.000 description 1
- 229960004484 carbachol Drugs 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 235000021256 carbohydrate metabolism Nutrition 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000020411 cell activation Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 230000036755 cellular response Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 125000003636 chemical group Chemical group 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000013626 chemical specie Substances 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- SIHHLZPXQLFPMC-UHFFFAOYSA-N chloroform;methanol;hydrate Chemical compound O.OC.ClC(Cl)Cl SIHHLZPXQLFPMC-UHFFFAOYSA-N 0.000 description 1
- VJYIFXVZLXQVHO-UHFFFAOYSA-N chlorsulfuron Chemical compound COC1=NC(C)=NC(NC(=O)NS(=O)(=O)C=2C(=CC=CC=2)Cl)=N1 VJYIFXVZLXQVHO-UHFFFAOYSA-N 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 238000012411 cloning technique Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- OHCQJHSOBUTRHG-UHFFFAOYSA-N colforsin Natural products OC12C(=O)CC(C)(C=C)OC1(C)C(OC(=O)C)C(O)C1C2(C)C(O)CCC1(C)C OHCQJHSOBUTRHG-UHFFFAOYSA-N 0.000 description 1
- 238000010835 comparative analysis Methods 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 238000003271 compound fluorescence assay Methods 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 108091036078 conserved sequence Proteins 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 235000014510 cooky Nutrition 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 229920005565 cyclic polymer Polymers 0.000 description 1
- 150000001945 cysteines Chemical class 0.000 description 1
- 102000003675 cytokine receptors Human genes 0.000 description 1
- 108010057085 cytokine receptors Proteins 0.000 description 1
- 125000001295 dansyl group Chemical group [H]C1=C([H])C(N(C([H])([H])[H])C([H])([H])[H])=C2C([H])=C([H])C([H])=C(C2=C1[H])S(*)(=O)=O 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 235000012869 dehydrated soup Nutrition 0.000 description 1
- 125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
- 230000000368 destabilizing effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000009025 developmental regulation Effects 0.000 description 1
- 150000001982 diacylglycerols Chemical class 0.000 description 1
- QONQRTHLHBTMGP-UHFFFAOYSA-N digitoxigenin Natural products CC12CCC(C3(CCC(O)CC3CC3)C)C3C11OC1CC2C1=CC(=O)OC1 QONQRTHLHBTMGP-UHFFFAOYSA-N 0.000 description 1
- SHIBSTMRCDJXLN-KCZCNTNESA-N digoxigenin Chemical compound C1([C@@H]2[C@@]3([C@@](CC2)(O)[C@H]2[C@@H]([C@@]4(C)CC[C@H](O)C[C@H]4CC2)C[C@H]3O)C)=CC(=O)OC1 SHIBSTMRCDJXLN-KCZCNTNESA-N 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000006471 dimerization reaction Methods 0.000 description 1
- 235000021186 dishes Nutrition 0.000 description 1
- BFMYDTVEBKDAKJ-UHFFFAOYSA-L disodium;(2',7'-dibromo-3',6'-dioxido-3-oxospiro[2-benzofuran-1,9'-xanthene]-4'-yl)mercury;hydrate Chemical compound O.[Na+].[Na+].O1C(=O)C2=CC=CC=C2C21C1=CC(Br)=C([O-])C([Hg])=C1OC1=C2C=C(Br)C([O-])=C1 BFMYDTVEBKDAKJ-UHFFFAOYSA-L 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 210000001671 embryonic stem cell Anatomy 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000007368 endocrine function Effects 0.000 description 1
- 235000021183 entrée Nutrition 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 150000002169 ethanolamines Chemical class 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 235000013861 fat-free Nutrition 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000019688 fish Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 1
- 238000002866 fluorescence resonance energy transfer Methods 0.000 description 1
- 238000001943 fluorescence-activated cell sorting Methods 0.000 description 1
- 239000003269 fluorescent indicator Substances 0.000 description 1
- 235000015219 food category Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 238000011842 forensic investigation Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 235000008378 frozen soup Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- YFHXZQPUBCBNIP-UHFFFAOYSA-N fura-2 Chemical compound CC1=CC=C(N(CC(O)=O)CC(O)=O)C(OCCOC=2C(=CC=3OC(=CC=3C=2)C=2OC(=CN=2)C(O)=O)N(CC(O)=O)CC(O)=O)=C1 YFHXZQPUBCBNIP-UHFFFAOYSA-N 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 229960003082 galactose Drugs 0.000 description 1
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 238000012215 gene cloning Methods 0.000 description 1
- 238000010363 gene targeting Methods 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 238000012248 genetic selection Methods 0.000 description 1
- BRZYSWJRSDMWLG-CAXSIQPQSA-N geneticin Natural products O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](C(C)O)O2)N)[C@@H](N)C[C@H]1N BRZYSWJRSDMWLG-CAXSIQPQSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-L glutamate group Chemical group N[C@@H](CCC(=O)[O-])C(=O)[O-] WHUUTDBJXJRKMK-VKHMYHEASA-L 0.000 description 1
- 150000002306 glutamic acid derivatives Chemical class 0.000 description 1
- 125000000291 glutamic acid group Chemical group N[C@@H](CCC(O)=O)C(=O)* 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 125000003827 glycol group Chemical group 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000002363 herbicidal effect Effects 0.000 description 1
- 239000004009 herbicide Substances 0.000 description 1
- 239000000833 heterodimer Substances 0.000 description 1
- 108091006093 heterotrimeric G proteins Proteins 0.000 description 1
- 102000034345 heterotrimeric G proteins Human genes 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 238000013537 high throughput screening Methods 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 150000001469 hydantoins Chemical class 0.000 description 1
- 239000012051 hydrophobic carrier Substances 0.000 description 1
- 125000001165 hydrophobic group Chemical group 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 238000003119 immunoblot Methods 0.000 description 1
- 230000000951 immunodiffusion Effects 0.000 description 1
- 238000000760 immunoelectrophoresis Methods 0.000 description 1
- 238000003125 immunofluorescent labeling Methods 0.000 description 1
- 229940072221 immunoglobulins Drugs 0.000 description 1
- 238000010324 immunological assay Methods 0.000 description 1
- 238000012750 in vivo screening Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229960003786 inosine Drugs 0.000 description 1
- 235000014109 instant soup Nutrition 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 102000006495 integrins Human genes 0.000 description 1
- 108010044426 integrins Proteins 0.000 description 1
- 102000002467 interleukin receptors Human genes 0.000 description 1
- 108010093036 interleukin receptors Proteins 0.000 description 1
- 102000027411 intracellular receptors Human genes 0.000 description 1
- 108091008582 intracellular receptors Proteins 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 239000007951 isotonicity adjuster Substances 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- BJHIKXHVCXFQLS-PQLUHFTBSA-N keto-D-tagatose Chemical compound OC[C@@H](O)[C@H](O)[C@H](O)C(=O)CO BJHIKXHVCXFQLS-PQLUHFTBSA-N 0.000 description 1
- 238000011813 knockout mouse model Methods 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229960001375 lactose Drugs 0.000 description 1
- 238000012177 large-scale sequencing Methods 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 150000002611 lead compounds Chemical class 0.000 description 1
- 239000002523 lectin Substances 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000013554 lipid monolayer Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000001638 lipofection Methods 0.000 description 1
- 230000004130 lipolysis Effects 0.000 description 1
- 239000012263 liquid product Substances 0.000 description 1
- 238000005567 liquid scintillation counting Methods 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- HWYHZTIRURJOHG-UHFFFAOYSA-N luminol Chemical compound O=C1NNC(=O)C2=C1C(N)=CC=C2 HWYHZTIRURJOHG-UHFFFAOYSA-N 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 235000021184 main course Nutrition 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 235000015090 marinades Nutrition 0.000 description 1
- 235000021180 meal component Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 102000006240 membrane receptors Human genes 0.000 description 1
- 108020004084 membrane receptors Proteins 0.000 description 1
- 230000008172 membrane trafficking Effects 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 238000000520 microinjection Methods 0.000 description 1
- ZAHQPTJLOCWVPG-UHFFFAOYSA-N mitoxantrone dihydrochloride Chemical compound Cl.Cl.O=C1C2=C(O)C=CC(O)=C2C(=O)C2=C1C(NCCNCCO)=CC=C2NCCNCCO ZAHQPTJLOCWVPG-UHFFFAOYSA-N 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004001 molecular interaction Effects 0.000 description 1
- 238000000302 molecular modelling Methods 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 239000002324 mouth wash Substances 0.000 description 1
- 229940051866 mouthwash Drugs 0.000 description 1
- 238000002887 multiple sequence alignment Methods 0.000 description 1
- 201000000050 myeloid neoplasm Diseases 0.000 description 1
- 239000000879 neohesperidine DC Substances 0.000 description 1
- 229960004927 neomycin Drugs 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 230000007372 neural signaling Effects 0.000 description 1
- 210000000461 neuroepithelial cell Anatomy 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 230000003957 neurotransmitter release Effects 0.000 description 1
- 108010087904 neutravidin Proteins 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 235000019520 non-alcoholic beverage Nutrition 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 229940127240 opiate Drugs 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 235000015927 pasta Nutrition 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 238000012402 patch clamp technique Methods 0.000 description 1
- 210000003200 peritoneal cavity Anatomy 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 239000002953 phosphate buffered saline Substances 0.000 description 1
- 150000004713 phosphodiesters Chemical class 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 235000015108 pies Nutrition 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 230000008488 polyadenylation Effects 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000412 polyarylene Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920002704 polyhistidine Polymers 0.000 description 1
- 229920001721 polyimide Polymers 0.000 description 1
- 238000003752 polymerase chain reaction Methods 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 230000029279 positive regulation of transcription, DNA-dependent Effects 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 235000013594 poultry meat Nutrition 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 239000002987 primer (paints) Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- AAEVYOVXGOFMJO-UHFFFAOYSA-N prometryn Chemical compound CSC1=NC(NC(C)C)=NC(NC(C)C)=N1 AAEVYOVXGOFMJO-UHFFFAOYSA-N 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- 230000004952 protein activity Effects 0.000 description 1
- 238000002331 protein detection Methods 0.000 description 1
- 230000006916 protein interaction Effects 0.000 description 1
- 238000001742 protein purification Methods 0.000 description 1
- 230000017854 proteolysis Effects 0.000 description 1
- 230000002797 proteolythic effect Effects 0.000 description 1
- 210000001938 protoplast Anatomy 0.000 description 1
- 235000011962 puddings Nutrition 0.000 description 1
- 150000003212 purines Chemical class 0.000 description 1
- 150000003230 pyrimidines Chemical class 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000000163 radioactive labelling Methods 0.000 description 1
- 238000002601 radiography Methods 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 239000002464 receptor antagonist Substances 0.000 description 1
- 229940044551 receptor antagonist Drugs 0.000 description 1
- 238000010188 recombinant method Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 125000002652 ribonucleotide group Chemical group 0.000 description 1
- 235000021462 rice dishes Nutrition 0.000 description 1
- 235000019643 salty taste Nutrition 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 238000010187 selection method Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 238000002741 site-directed mutagenesis Methods 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- IFGCUJZIWBUILZ-UHFFFAOYSA-N sodium 2-[[2-[[hydroxy-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyphosphoryl]amino]-4-methylpentanoyl]amino]-3-(1H-indol-3-yl)propanoic acid Chemical compound [Na+].C=1NC2=CC=CC=C2C=1CC(C(O)=O)NC(=O)C(CC(C)C)NP(O)(=O)OC1OC(C)C(O)C(O)C1O IFGCUJZIWBUILZ-UHFFFAOYSA-N 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 238000010532 solid phase synthesis reaction Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 210000004989 spleen cell Anatomy 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 235000019207 sweet taste enhancer Nutrition 0.000 description 1
- 230000035918 sweet taste sensation Effects 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 150000003536 tetrazoles Chemical class 0.000 description 1
- MPLHNVLQVRSVEE-UHFFFAOYSA-N texas red Chemical compound [O-]S(=O)(=O)C1=CC(S(Cl)(=O)=O)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 MPLHNVLQVRSVEE-UHFFFAOYSA-N 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- 150000003573 thiols Chemical class 0.000 description 1
- 108060008226 thioredoxin Proteins 0.000 description 1
- 229940094937 thioredoxin Drugs 0.000 description 1
- 229940113082 thymine Drugs 0.000 description 1
- 239000005495 thyroid hormone Substances 0.000 description 1
- 229940036555 thyroid hormone Drugs 0.000 description 1
- 230000001550 time effect Effects 0.000 description 1
- 229940034610 toothpaste Drugs 0.000 description 1
- 239000000606 toothpaste Substances 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 230000005026 transcription initiation Effects 0.000 description 1
- 239000012581 transferrin Substances 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000011830 transgenic mouse model Methods 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 230000010474 transient expression Effects 0.000 description 1
- 102000027257 transmembrane receptors Human genes 0.000 description 1
- 108091008578 transmembrane receptors Proteins 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 108010063331 type 2 taste receptors Proteins 0.000 description 1
- ORHBXUUXSCNDEV-UHFFFAOYSA-N umbelliferone Chemical compound C1=CC(=O)OC2=CC(O)=CC=C21 ORHBXUUXSCNDEV-UHFFFAOYSA-N 0.000 description 1
- HFTAFOQKODTIJY-UHFFFAOYSA-N umbelliferone Natural products Cc1cc2C=CC(=O)Oc2cc1OCC=CC(C)(C)O HFTAFOQKODTIJY-UHFFFAOYSA-N 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
- 241001430294 unidentified retrovirus Species 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 239000013603 viral vector Substances 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 238000011179 visual inspection Methods 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
- 150000003952 β-lactams Chemical class 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/56—Flavouring or bittering agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/20—Synthetic spices, flavouring agents or condiments
- A23L27/202—Aliphatic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/20—Synthetic spices, flavouring agents or condiments
- A23L27/203—Alicyclic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/20—Synthetic spices, flavouring agents or condiments
- A23L27/205—Heterocyclic compounds
- A23L27/2054—Heterocyclic compounds having nitrogen as the only hetero atom
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/88—Taste or flavour enhancing agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
- C07C233/65—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C235/54—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C275/30—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by halogen atoms, or by nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C275/32—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms
- C07C275/34—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms having nitrogen atoms of urea groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/40—Acylated substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/84—Nitriles
- C07D213/85—Nitriles in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C07D217/06—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/56—Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/12—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/02—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
- C07D275/03—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
- C07D285/125—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
- C07D285/135—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D307/84—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
- C07D317/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
- C07F9/65515—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring
- C07F9/65517—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring condensed with carbocyclic rings or carbocyclic ring systems
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
- G01N33/5041—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects involving analysis of members of signalling pathways
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
- G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Food Science & Technology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Birds (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Toxicology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Seasonings (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims
Priority Applications (22)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BRPI0413324-2A BRPI0413324A (en) | 2003-08-06 | 2004-08-06 | t1r hetero-oligomeric taste receptors, cell lines expressing said receptors, and taste compounds |
JP2006522754A JP2007512227A (en) | 2003-08-06 | 2004-08-06 | T1R hetero-oligomer taste receptor, cell line expressing this receptor, and taste compound |
CA002535045A CA2535045A1 (en) | 2003-08-06 | 2004-08-06 | T1r hetero-oligomeric taste receptors, cell lines that express said receptors, and taste compounds |
NZ545747A NZ545747A (en) | 2003-08-06 | 2004-08-06 | T1R hetero-oligomeric taste receptors, cell lines that express said receptors, and taste compounds |
US10/569,870 US20070104709A1 (en) | 2003-08-06 | 2004-08-06 | T1r hetero-oligomeric taste receptors, cell lines that express said receptors, and taste compounds |
EP04780314A EP1660859A4 (en) | 2003-08-06 | 2004-08-06 | T1r hetero-oligomeric taste receptors, cell lines that express said receptors, and taste compounds |
MXPA06001510A MXPA06001510A (en) | 2003-08-06 | 2004-08-06 | T1r hetero-oligomeric taste receptors, cell lines that express said receptors, and taste compounds. |
RU2006106920/13A RU2006106920A (en) | 2003-08-06 | 2004-08-06 | T1R HETERO-OLIGOMER TASTE RECEPTORS, CELL LINES THAT EXPRESS THE SPECIFIED RECEPTORS AND TASTE COMPOUNDS |
AU2004263871A AU2004263871B2 (en) | 2003-08-06 | 2004-08-06 | T1R hetero-oligomeric taste receptors, cell lines that express said receptors, and taste compounds |
IL173552A IL173552A (en) | 2003-08-06 | 2006-02-06 | T1r hetero-oligomeric taste receptors, cell lines that express said receptors and taste compounds |
US11/583,097 US7906627B2 (en) | 2003-08-06 | 2006-10-19 | Chimeric human sweet-umami and umami-sweet taste receptors |
US11/879,364 US7888470B2 (en) | 2003-08-06 | 2007-07-17 | Chimeric T1R taste receptor polypeptides and nucleic acid sequences encoding and cell lines that express said chimeric T1R polypeptides |
US12/852,941 US8404455B2 (en) | 2003-08-06 | 2010-08-09 | Chimeric T1R taste receptor polypeptides and nucleic acid sequences encoding and cell lines that express said chimeric T1R polypeptides |
IL207954A IL207954A0 (en) | 2003-08-06 | 2010-09-02 | T1r hetero-oligomeric taste receptors, binding compounds and uses thereof |
US13/020,068 US8247184B2 (en) | 2003-08-06 | 2011-02-03 | Assays using chimeric T1R polypeptides for identifying putative taste modulatory compounds |
US13/417,660 US8735081B2 (en) | 2003-08-06 | 2012-03-12 | T1R hetero-oligomeric taste receptors, cell lines that express said receptors, and taste compounds |
US13/770,251 US9091686B2 (en) | 2003-08-06 | 2013-02-19 | Chimeric T1R taste receptor polypeptides and nucleic acid sequences encoding and cell lines that express said chimeric T1R polypeptides |
US14/477,027 US9459250B2 (en) | 2003-08-06 | 2014-09-04 | Use of T1R3 venus flytrap region polypeptide to screen for taste modulators |
PH12016501312A PH12016501312A1 (en) | 2003-08-06 | 2016-06-30 | T1r hetero-oligomeric taste receptors, cell lines that express said receptors, and taste compounds |
PH12016501311A PH12016501311A1 (en) | 2003-08-06 | 2016-06-30 | T1r hetero-oligomeric taste receptors, cell lines that express said receptors, and taste compounds |
US15/244,135 US10352929B2 (en) | 2003-08-06 | 2016-08-23 | T1R hetero-oligomeric taste receptors, cell lines that express said receptors, and taste compounds |
US16/437,049 US20200049699A1 (en) | 2003-08-06 | 2019-06-11 | T1r hetero-oligomeric taste receptors, cell lines that express said receptors, and taste compounds |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US49407103P | 2003-08-06 | 2003-08-06 | |
US60/494,071 | 2003-08-06 | ||
US55206404P | 2004-03-09 | 2004-03-09 | |
US60/552,064 | 2004-03-09 |
Related Child Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/569,870 A-371-Of-International US20070104709A1 (en) | 2003-08-06 | 2004-08-06 | T1r hetero-oligomeric taste receptors, cell lines that express said receptors, and taste compounds |
US11/583,097 Continuation-In-Part US7906627B2 (en) | 2003-08-06 | 2006-10-19 | Chimeric human sweet-umami and umami-sweet taste receptors |
US11/879,364 Continuation US7888470B2 (en) | 2003-08-06 | 2007-07-17 | Chimeric T1R taste receptor polypeptides and nucleic acid sequences encoding and cell lines that express said chimeric T1R polypeptides |
US12/852,941 Continuation US8404455B2 (en) | 2003-08-06 | 2010-08-09 | Chimeric T1R taste receptor polypeptides and nucleic acid sequences encoding and cell lines that express said chimeric T1R polypeptides |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2005015158A2 true WO2005015158A2 (en) | 2005-02-17 |
WO2005015158A9 WO2005015158A9 (en) | 2005-05-19 |
WO2005015158A3 WO2005015158A3 (en) | 2007-01-04 |
Family
ID=34138798
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2004/025419 WO2005041684A2 (en) | 2003-08-06 | 2004-08-06 | Novel flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof |
PCT/US2004/025459 WO2005015158A2 (en) | 2003-08-06 | 2004-08-06 | T1r hetero-oligomeric taste receptors, cell lines that express said receptors, and taste compounds |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2004/025419 WO2005041684A2 (en) | 2003-08-06 | 2004-08-06 | Novel flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof |
Country Status (19)
Country | Link |
---|---|
US (15) | US7476399B2 (en) |
EP (3) | EP3431464A3 (en) |
JP (4) | JP2007512227A (en) |
CN (1) | CN103275058B (en) |
AR (1) | AR046078A1 (en) |
AU (3) | AU2004285410B2 (en) |
BR (2) | BRPI0413347A (en) |
CA (3) | CA2900181C (en) |
CL (2) | CL2004002015A1 (en) |
ES (1) | ES2733577T3 (en) |
IL (3) | IL173551A (en) |
MX (1) | MXPA06001510A (en) |
MY (1) | MY174572A (en) |
NZ (6) | NZ627505A (en) |
PH (8) | PH12015501666B1 (en) |
RU (3) | RU2419602C2 (en) |
SG (2) | SG145745A1 (en) |
WO (2) | WO2005041684A2 (en) |
ZA (1) | ZA200601904B (en) |
Cited By (60)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006099762A1 (en) * | 2005-03-24 | 2006-09-28 | Givaudan Sa | Cooling compounds |
WO2007047988A2 (en) | 2005-10-20 | 2007-04-26 | Senomyx, Inc. | Chimeric human sweet-umami and umami-sweet taste receptors |
US7223551B2 (en) | 2000-03-07 | 2007-05-29 | Senomyx, Inc. | T1R3 receptor binding assays for identification of taste modulatory compounds |
WO2007121599A1 (en) | 2006-04-20 | 2007-11-01 | Givaudan Sa | Functional method to identify tastants |
US7294474B2 (en) | 2001-06-26 | 2007-11-13 | Senomyx, Inc. | Functional assays for identifying compounds that modulate T1R2/T1R3 (sweet) taste |
US7301009B2 (en) | 2001-06-26 | 2007-11-27 | Senomyx, Inc. | Isolated (T1R1/T1R3) umami taste receptors that respond to umami taste stimuli |
US7309577B2 (en) | 2001-03-07 | 2007-12-18 | Senomyx, Inc. | Binding assays that use the T1R1/T1R3 (umami) taste receptor to identify compounds that elicit or modulate umami taste |
WO2007147275A1 (en) * | 2006-06-19 | 2007-12-27 | Givaudan Sa | Nucleic acid, polypeptide and its use |
WO2008086634A2 (en) * | 2007-01-18 | 2008-07-24 | Givaudan Sa | Chimeric umami taste receptor, nucleic acid encoding it and use thereof |
JP2008530020A (en) * | 2005-02-04 | 2008-08-07 | セノミックス インコーポレイテッド | Aromatic amides and ureas, and sweetness and / or umami modifiers, umami and / or sweeteners and their use as umami enhancers and / or sweet taste improvers |
US7419791B2 (en) | 2001-04-19 | 2008-09-02 | Senomyx, Inc. | Methods of screening compounds using a T1R3 hetero-oligomeric taste receptor |
US7435552B2 (en) | 2001-01-03 | 2008-10-14 | Senomyx, Inc | Binding assays that use human T1R2 to identify potential taste modulators |
JP2008543313A (en) * | 2005-06-15 | 2008-12-04 | セノミックス インコーポレイテッド | Diaromatic amides and their use as flavoring and flavoring or flavor enhancers |
US7476399B2 (en) | 2003-08-06 | 2009-01-13 | Senomyx Inc. | Flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof |
US20090181404A1 (en) * | 2006-07-28 | 2009-07-16 | Guy Servant | Cell-based fluorescent assays for identifying alpha and delta EnaC modulators |
WO2009111447A2 (en) | 2008-03-03 | 2009-09-11 | Senomyx, Inc. | Isosorbide derivatives and their use as flavor modifiers, tastants, and taste enhancers |
US20100009385A1 (en) * | 2001-05-01 | 2010-01-14 | Bryan Moyer | Assays and enhancers of the human delta enac sodium channel |
US7763431B1 (en) | 2001-03-07 | 2010-07-27 | Senomyx, Inc. | Binding assays that use the T1R2/T1R3 (sweet) taste receptor to identify compounds that elicit or modulate sweet taste |
US7906627B2 (en) | 2003-08-06 | 2011-03-15 | Senomyx, Inc. | Chimeric human sweet-umami and umami-sweet taste receptors |
US7910322B2 (en) | 2001-03-07 | 2011-03-22 | Senomyx, Inc. | Methods for identifying compounds that modulate T1R1/T1R3 umami taste receptors |
WO2011039340A2 (en) | 2009-10-02 | 2011-04-07 | Givaudan Sa | Flavour enhancement |
WO2011095533A1 (en) | 2010-02-04 | 2011-08-11 | Givaudan Sa | Oxalamide derivative as umami flavouring agent |
US20120122842A1 (en) * | 2010-11-15 | 2012-05-17 | Abbott Laboratories | Nampt and rock inhibitors |
EP2520647A1 (en) * | 2009-12-02 | 2012-11-07 | T. Hasegawa Co., Ltd. | Sweet taste receptor expression construct, cell body expressing same, and uses therefor |
EP2568287A2 (en) * | 2007-06-08 | 2013-03-13 | Senomyx, Inc. | Modulation of chemosensory receptors and ligands associated |
WO2013060816A1 (en) | 2011-10-26 | 2013-05-02 | Givaudan Sa | Organic compounds |
WO2013060814A2 (en) | 2011-10-26 | 2013-05-02 | Givaudan Sa | Organic compounds |
WO2013060813A1 (en) | 2011-10-26 | 2013-05-02 | Givaudan Sa | Organic compounds |
WO2013060815A1 (en) | 2011-10-26 | 2013-05-02 | Givaudan Sa | Organic compounds |
WO2013060812A2 (en) | 2011-10-26 | 2013-05-02 | Givaudan Sa | Organic compounds |
USRE44339E1 (en) | 2003-11-21 | 2013-07-02 | Givaudan S.A. | N-substituted P-menthane carboxamides |
WO2012054530A3 (en) * | 2010-10-19 | 2013-10-31 | Elcelyx Therapeutics, Inc. | Chemosensory receptor ligand-based therapies |
US8784782B2 (en) | 2005-02-04 | 2014-07-22 | Senomyx, Inc. | Compounds comprising linked heteroaryl moieties and their use as novel umami flavor modifiers, tastants and taste enhancers for comestible compositions |
US8877922B2 (en) | 2012-08-06 | 2014-11-04 | Senomyx, Inc. | Sweet flavor modifier |
WO2015000900A2 (en) | 2013-07-01 | 2015-01-08 | Givaudan Sa | Organic compounds |
US9000151B2 (en) | 2013-02-19 | 2015-04-07 | Senomyx, Inc. | Sweet flavor modifier |
JP2015091242A (en) * | 2006-04-20 | 2015-05-14 | ジボダン エス エー | Method for enhancing sweetness |
US9049878B2 (en) | 2010-04-02 | 2015-06-09 | Senomyx, Inc. | Sweet flavor modifier |
US9072313B2 (en) | 2006-04-21 | 2015-07-07 | Senomyx, Inc. | Comestible compositions comprising high potency savory flavorants, and processes for producing them |
EP2924050A1 (en) * | 2014-03-28 | 2015-09-30 | Ajinomoto Co., Inc. | Sweet taste receptor chimeric proteins and use thereof |
WO2016118882A1 (en) * | 2015-01-23 | 2016-07-28 | cP2 SCIENCE, INC. | Fragrance and flavor compositions comprising neopentyl glycol diacetate |
US9603848B2 (en) | 2007-06-08 | 2017-03-28 | Senomyx, Inc. | Modulation of chemosensory receptors and ligands associated therewith |
CN106620144A (en) * | 2016-12-29 | 2017-05-10 | 姜富春 | Traditional Chinese medicine preparation for treating chronic pelvic inflammation and preparation method thereof |
US9732052B2 (en) | 2008-07-31 | 2017-08-15 | Senomyx, Inc. | Processes and intermediates for making sweet taste enhancers |
US9804157B1 (en) | 2013-03-15 | 2017-10-31 | Senomyx, Inc. | Screening assays to identify compounds which modulate T1R associated taste modalities which eliminate false positives |
US9834544B2 (en) | 2010-04-02 | 2017-12-05 | Senomyx, Inc. | Sweet flavor modifier |
US10048274B2 (en) | 2003-07-10 | 2018-08-14 | Senomyx Inc. | Electrophysiological assays using oocytes that express human ENaC and the use of phenamil to improve the effect of ENaC enhancers in assays using membrane potential reporting dyes |
US10226062B2 (en) | 2013-12-05 | 2019-03-12 | Givaudan Sa | Organic compounds |
US10299999B2 (en) | 2011-02-23 | 2019-05-28 | Givaudan S.A. | Flavour composition comprising menthol and menthane carboxamides |
AU2017200704B2 (en) * | 2007-06-08 | 2019-10-31 | Firmenich Incorporated | Modulation of chemosensory receptors and ligands associated therewith |
WO2020251928A1 (en) * | 2019-06-12 | 2020-12-17 | Corn Products Development, Inc. | Compositions with sugar like characteristics |
WO2021063942A1 (en) | 2019-09-30 | 2021-04-08 | Givaudan Sa | Improvements in or relating to organic compounds |
US11060124B2 (en) | 2017-05-03 | 2021-07-13 | Firmenich Incorporated | Methods for making high intensity sweeteners |
WO2021175751A1 (en) * | 2020-03-05 | 2021-09-10 | Firmenich Sa | 11-oxo-cucurbitanes and their use as flavor modifiers |
US11339128B2 (en) | 2014-11-07 | 2022-05-24 | Firmenich Incorporated | Substituted 4-amino-5-(cyclohexyloxy)quinoline-3-carboxylic acids as sweet flavor modifiers |
US11357246B2 (en) | 2015-10-29 | 2022-06-14 | Firmenich Incorporated | High intensity sweeteners |
WO2023091315A3 (en) * | 2021-11-16 | 2023-07-20 | Firmenich Incorporated | Amide compounds and their use as flavor modifiers |
WO2023154597A1 (en) * | 2022-02-11 | 2023-08-17 | Firmenich Incorporated | Cells expressing umami taste receptors and uses thereof |
WO2023172372A1 (en) * | 2022-03-11 | 2023-09-14 | Firmenich Incorporated | Amide compounds and their use as flavor modifiers |
US11945813B2 (en) | 2018-08-07 | 2024-04-02 | Firmenich Incorporated | 5-substituted 4-amino-1H-benzo[c][1,2,6]thiadiazine 2,2-dioxides and formulations and uses thereof |
Families Citing this family (160)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7794959B2 (en) * | 2001-04-05 | 2010-09-14 | Senomyx, Inc. | Identification of bitter receptors for hydrolyzed soy protein |
CA2477604A1 (en) | 2002-03-13 | 2003-09-25 | Signum Biosciences, Inc. | Modulation of protein methylation and phosphoprotein phosphate |
US7427421B2 (en) * | 2004-09-10 | 2008-09-23 | International Flavors & Fragrances Inc. | Saturated and unsaturated N-alkamides exhibiting taste and flavor enhancement effect in flavor compositions |
US7541055B2 (en) * | 2004-09-10 | 2009-06-02 | International Flavors & Fragrances Inc. | Saturated and unsaturated N-alkamides exhibiting taste and flavor enhancement effect in flavor compositions |
GB0425661D0 (en) * | 2004-11-23 | 2004-12-22 | Givaudan Sa | Organic compounds |
WO2006068745A1 (en) | 2004-12-22 | 2006-06-29 | Cargill, Incorporated | Methods for determining cellular response to stimuli |
US8221804B2 (en) * | 2005-02-03 | 2012-07-17 | Signum Biosciences, Inc. | Compositions and methods for enhancing cognitive function |
US7923041B2 (en) | 2005-02-03 | 2011-04-12 | Signum Biosciences, Inc. | Compositions and methods for enhancing cognitive function |
TW200638882A (en) * | 2005-02-04 | 2006-11-16 | Senomyx Inc | Molecules comprising linked organic moieties as flavor modifiers for comestible compositions |
US7560465B2 (en) * | 2005-03-31 | 2009-07-14 | Richard Holschen | Compositions and methods for delivery of caffeine |
EP2305046A3 (en) | 2005-05-23 | 2014-04-09 | Intercontinental Great Brands LLC | Taste potentiator compositions and beverages containing the same |
US7851006B2 (en) | 2005-05-23 | 2010-12-14 | Cadbury Adams Usa Llc | Taste potentiator compositions and beverages containing same |
US7851005B2 (en) | 2005-05-23 | 2010-12-14 | Cadbury Adams Usa Llc | Taste potentiator compositions and beverages containing same |
EP2368442B1 (en) | 2005-07-27 | 2014-12-17 | Symrise AG | Use of hesperetin for enhancing the sweet taste |
KR101219281B1 (en) * | 2005-10-31 | 2013-01-08 | (주)아모레퍼시픽 | Gentisic acid derivatives and preparation method thereof and whitening cosmetic composition containing it |
KR20080069233A (en) * | 2005-11-04 | 2008-07-25 | 아지노모토 가부시키가이샤 | Gastrointestinal function promoter |
EP2299271B9 (en) * | 2005-11-09 | 2014-02-26 | Ajinomoto Co., Inc. | Kokumi-imparting compositions |
US9101160B2 (en) | 2005-11-23 | 2015-08-11 | The Coca-Cola Company | Condiments with high-potency sweetener |
JP5374157B2 (en) * | 2005-11-24 | 2013-12-25 | ドムペ・ファ.ル.マ・ソチエタ・ペル・アツィオーニ | (R) -Arylalkylamino derivatives and pharmaceutical compositions containing them |
US8007849B2 (en) * | 2005-12-14 | 2011-08-30 | International Flavors & Fragrances Inc. | Unsaturated cyclic and acyclic carbamates exhibiting taste and flavor enhancement effect in flavor compositions |
CN101426381A (en) * | 2006-04-21 | 2009-05-06 | 西诺米克斯公司 | Comestible compositions comprising high potency savory flavorants, and processes for producing them |
BRPI0716053A2 (en) * | 2006-08-22 | 2013-08-06 | Redpoint Bio Corp | heterocyclic compounds as sweetener promoters |
US8017168B2 (en) | 2006-11-02 | 2011-09-13 | The Coca-Cola Company | High-potency sweetener composition with rubisco protein, rubiscolin, rubiscolin derivatives, ace inhibitory peptides, and combinations thereof, and compositions sweetened therewith |
EP1955601A1 (en) | 2007-01-25 | 2008-08-13 | Symrise GmbH & Co. KG | Use of propenylphenylglycosides for intensifying sweet sensory impressions |
EP1977655B1 (en) | 2007-03-29 | 2011-05-18 | Symrise AG | Aroma compositions of alkamides with hesperetin and/or 4-hydroxydihydrochalkones and their salts for reinforcing sweet sensory impressions |
US8765207B2 (en) * | 2007-04-10 | 2014-07-01 | Paul Coles | Fruit product containing sugar alcohol |
DE502008000732D1 (en) * | 2007-05-08 | 2010-07-15 | Symrise Gmbh & Co Kg | Substituted cyclopropanecarboxylic acid (3-methylcyclohexyl) amides as flavoring agents |
AU2008254960B2 (en) | 2007-05-17 | 2014-11-27 | Cortex Pharmaceuticals, Inc. | Di-substituted amides for enhancing glutamatergic synaptic responses |
US8709521B2 (en) * | 2007-05-22 | 2014-04-29 | The Coca-Cola Company | Sweetener compositions having enhanced sweetness and improved temporal and/or flavor profiles |
US20080305500A1 (en) * | 2007-06-08 | 2008-12-11 | Senomyx, Inc. | Novel cell-based assays for identifying enhancers or inhibitors of t1r taste receptors (t1r2/t1r3 sweet) and umami (t1r1/t1r3 umami) taste receptors |
US8633186B2 (en) | 2007-06-08 | 2014-01-21 | Senomyx Inc. | Modulation of chemosensory receptors and ligands associated therewith |
EP2179651A4 (en) * | 2007-06-29 | 2012-07-11 | Sumitomo Chemical Co | Plant disease control agent, and plant disease control method |
EP2064959B1 (en) | 2007-10-31 | 2012-07-25 | Symrise AG | Aromatic Neomenthylamides as flavouring agents |
WO2009100040A2 (en) * | 2008-02-01 | 2009-08-13 | Chromocell Corporation | Cell lines expressing gabaa and methods using them |
WO2009132051A1 (en) | 2008-04-21 | 2009-10-29 | Signum Biosciences, Inc. | Compounds, compositions and methods for making the same |
EP2135516B1 (en) * | 2008-06-13 | 2012-08-15 | Symrise AG | Neo-menthyl derivatives as flavourings |
RU2511315C2 (en) * | 2008-07-31 | 2014-04-10 | Синомикс, Инк. | Compositions, containing sweet flavour enhancers, and methods of obtaining them |
DE102008042421A1 (en) | 2008-09-26 | 2010-04-01 | Symrise Gmbh & Co. Kg | Geranylamine derivatives of oxalic acid |
CN101411461B (en) * | 2008-12-04 | 2012-02-29 | 广西大学 | Delicate flavor condiment similar to delicate flavor of steamed crab and method of processing the same |
NZ593294A (en) * | 2009-01-29 | 2013-04-26 | Commw Scient Ind Res Org | Measuring g protein coupled receptor activation |
PL216572B1 (en) * | 2009-02-02 | 2014-04-30 | Inst Chemii Organicznej Polska Akademia Nauk | Enaminocarbonylic compounds and their application |
DE102009002268A1 (en) | 2009-04-07 | 2010-10-14 | Leibniz-Institut Für Pflanzenbiochemie | Use of 4,4'-dihydroxydeoxybenzoin compound for masking or reducing unpleasant taste of an unpleasant tasting material, and/or strengthening the sweet tasting material of sweet material |
EP2253226B1 (en) | 2009-05-15 | 2015-07-15 | Leibniz-Institut für Pflanzenbiochemie (IPB) | Use of hydroxyflavone derivatives for modifying taste |
BR112012002979A2 (en) * | 2009-08-10 | 2015-09-01 | Stokely Van Camp Inc | Method for suspending a flavonoid in a drink |
ATE528997T1 (en) | 2009-08-28 | 2011-11-15 | Symrise Ag | SWEETENER-REDUCED PRODUCTS, FLAVOR MIXTURES THEREOF AND METHOD FOR PRODUCING SUCH PRODUCTS |
US10624372B2 (en) | 2009-08-28 | 2020-04-21 | Symrise Ag | Reduced-sweetener products, flavoring mixtures for said reduced-sweetener products and process for the production of products of this type |
US8293299B2 (en) | 2009-09-11 | 2012-10-23 | Kraft Foods Global Brands Llc | Containers and methods for dispensing multiple doses of a concentrated liquid, and shelf stable Concentrated liquids |
US20120245213A1 (en) * | 2009-10-01 | 2012-09-27 | Bedrich Mosinger | Human type i taste receptor subunit 3 modulators and methods of using same |
DE102009046126A1 (en) | 2009-10-28 | 2011-05-12 | Symrise Ag | Orally consumable preparation, useful e.g. in cosmetic preparation e.g. lipstick and as baked goods, comprises naturally occurring sweet-tasting substances and a root extract of Mondia whitei containing 2-hydroxy-4-methoxybenzaldehyde |
JP2011116693A (en) * | 2009-12-02 | 2011-06-16 | Univ Of Tokyo | Sweet taste-regulating substance acting on human sweet taste receptor for sweet taste substance |
CN102858192A (en) * | 2009-12-18 | 2013-01-02 | 斯托克里-丰康普公司 | Protein recovery beverage |
PL2353403T3 (en) | 2010-02-01 | 2012-10-31 | Symrise Ag | Use of 1-(2,4-dihydroxy-phenyl)-3-(3-hydroxy-4-methoxy-phenyl)-propan-1-on |
JP2013523192A (en) * | 2010-04-15 | 2013-06-17 | クロモセル コーポレーション | Compounds, compositions and methods for reducing or eliminating bitterness |
RU2576451C2 (en) * | 2010-08-12 | 2016-03-10 | Синомикс, Инк. | Method for improvement of stability of sweet taste intensifiers and composition containing stabilised sweet taste intensifier |
US8956859B1 (en) | 2010-08-13 | 2015-02-17 | Aviex Technologies Llc | Compositions and methods for determining successful immunization by one or more vaccines |
WO2012054528A2 (en) * | 2010-10-19 | 2012-04-26 | Elcelyx Therapeutics, Inc. | Chemosensory receptor ligand-based therapies |
EP2629617A4 (en) * | 2010-10-19 | 2014-08-27 | Elcelyx Therapeutics Inc | Chemosensory receptor ligand-based therapies |
CN103260434B (en) * | 2010-11-30 | 2016-08-10 | 荷兰联合利华有限公司 | Refined plant separator and thus plant separator produce the method for functional food ingredients |
ES2656944T3 (en) | 2011-04-29 | 2018-03-01 | Intercontinental Great Brands Llc | Encapsulated acid, method of preparation thereof, and chewing gum comprising it |
EP2529632B1 (en) | 2011-05-31 | 2013-08-28 | Symrise AG | Cinnamic acid amides as spicy flavour agents |
EP2529633B1 (en) | 2011-06-01 | 2014-08-06 | Symrise AG | Orally consumed preparations comprising particular sweet tasting triterpenes and triterpene glycosides |
CN102311352B (en) * | 2011-07-11 | 2013-10-16 | 上海应用技术学院 | Synthesis method for 2-methoxy-4-methylbenzylamine |
EP2742350B1 (en) | 2011-08-08 | 2019-10-30 | The Coca-Cola Company | Cell lines comprising endogenous taste receptors and their uses |
EP2570036B1 (en) | 2011-09-15 | 2014-06-18 | Symrise AG | Use of particular neoflavanoids for reinforcing and/or generating a sweet sensory sensation |
WO2013135511A1 (en) | 2012-03-12 | 2013-09-19 | Imax Discovery Gmbh | N-(2,4-dimethylpentan-3-yl)-methylbenzamides and their use as flavoring agents |
WO2013143822A1 (en) | 2012-03-26 | 2013-10-03 | Imax Discovery Gmbh | Adenosine as sweetness enhancer for certain sugars |
WO2013158928A2 (en) | 2012-04-18 | 2013-10-24 | Elcelyx Therapeutics, Inc. | Chemosensory receptor ligand-based therapies |
US11013248B2 (en) | 2012-05-25 | 2021-05-25 | Kraft Foods Group Brands Llc | Shelf stable, concentrated, liquid flavorings and methods of preparing beverages with the concentrated liquid flavorings |
EP2737807B1 (en) * | 2012-11-30 | 2017-04-05 | Symrise AG | Use of nitrogen-containing derivatives of cinnamic acid as flavourants |
EP2742983B1 (en) | 2012-12-11 | 2017-08-23 | Symrise AG | Method for isolating fragrance and flavour compounds |
WO2014095564A1 (en) * | 2012-12-21 | 2014-06-26 | Firmenich Sa | Taste-modifying combinations |
US9169311B2 (en) | 2013-03-15 | 2015-10-27 | Applied Food Biotechnology, Inc. | Feline bitter taste receptors and methods |
AU2014237801B2 (en) | 2013-03-15 | 2017-08-10 | Applied Food Biotechnology, Inc. | Feline bitter taste receptors and methods |
EP2832234A1 (en) | 2013-07-30 | 2015-02-04 | IMAX Discovery GmbH | Imidazo[1,2-a]pyridine-ylmethyl-derivatives and their use as flavoring agents |
EP2832233A1 (en) * | 2013-07-30 | 2015-02-04 | IMAX Discovery GmbH | 1H-pyrrole-2,4-dicarbonyl-derivatives and their use as flavoring agents |
CA2941192A1 (en) | 2013-09-11 | 2015-03-19 | Bristol-Myers Squibb Company | Aryl ether-base kinase inhibitors |
EP3071205B1 (en) | 2013-11-18 | 2020-02-05 | Forma Therapeutics, Inc. | Benzopiperazine compositions as bet bromodomain inhibitors |
MX370535B (en) | 2013-11-18 | 2019-12-17 | Forma Therapeutics Inc | Tetrahydroquinoline compositions as bet bromodomain inhibitors. |
EP2883459B1 (en) | 2013-12-16 | 2018-04-04 | Symrise AG | Compositions for oral consumption |
EP2918270A1 (en) | 2014-03-12 | 2015-09-16 | Symrise AG | Derivatives of aromatic alkenoic acids for curbing appetite and enhancing mood |
US10429560B2 (en) * | 2014-03-26 | 2019-10-01 | Lg Chem, Ltd. | Methods for manufacturing polarizing element, polarizing element roll and single sheet type polarizing element having local bleaching areas |
JP6479050B2 (en) * | 2014-05-09 | 2019-03-06 | フイルメニツヒ ソシエテ アノニムFirmenich Sa | Solubilization of sweetness modifiers and flavors |
CN106998771B (en) * | 2014-12-10 | 2021-06-22 | 马斯公司 | Flavour composition and pet food comprising same |
MX2018004049A (en) | 2015-10-01 | 2018-09-28 | Senomyx Inc | Compounds useful as modulators of trpm8. |
CN108463120A (en) * | 2016-02-03 | 2018-08-28 | 弗门尼舍有限公司 | The solution and dispersion liquid of amide compound |
RS61004B1 (en) | 2016-09-21 | 2020-11-30 | Celanese Int Corp | Acesulfame potassium compositions and processes for producing same |
EP3753930A1 (en) | 2016-09-21 | 2020-12-23 | Celanese International Corporation | Acesulfame potassium compositions and processes for producing same |
ES2763930T3 (en) | 2016-09-21 | 2020-06-01 | Celanese Int Corp | Potassium acesulfame compositions and processes to produce them |
LT3319948T (en) | 2016-09-21 | 2021-10-11 | Celanese International Corporation | Acesulfame potassium compositions and processes for producing same |
WO2019055464A1 (en) * | 2017-09-12 | 2019-03-21 | Monell Chemical Senses Center | Compositions and methods for regulation of immune cell activation and proliferation |
BR112020004933A2 (en) * | 2017-09-13 | 2020-09-15 | Syngenta Participations Ag | microbiocidal derivatives of quinoline (thio) carboxamide |
JP7173980B2 (en) | 2017-10-23 | 2022-11-17 | 日本たばこ産業株式会社 | Constructs for expressing G protein-coupled receptors or subunits thereof and uses thereof |
WO2020015816A1 (en) | 2018-07-16 | 2020-01-23 | Symrise Ag | Composition for substituting sugar in baked goods |
BR112021001176A2 (en) | 2018-08-10 | 2021-04-27 | Firmenich Incorporated | 2tr54 antagonists and compositions and uses thereof |
WO2020147977A1 (en) | 2019-01-18 | 2020-07-23 | Symrise Ag | Combination remedy |
EP3704954A1 (en) | 2019-03-05 | 2020-09-09 | Symrise AG | Mixture comprising d-allulose and taste modifying compounds |
WO2020193321A1 (en) | 2019-03-28 | 2020-10-01 | Firmenich Sa | Flavor system |
US20220017563A1 (en) | 2019-04-04 | 2022-01-20 | Firmenich Sa | Mogroside compounds and uses thereof |
BR112021014587A2 (en) | 2019-06-28 | 2022-01-04 | Firmenich & Cie | Fat mixtures, emulsions thereof and related uses |
JP2022547292A (en) | 2019-09-05 | 2022-11-11 | フイルメニツヒ ソシエテ アノニム | Flavanone derivatives and use of flavanone derivatives as sweetness enhancers |
WO2021094268A1 (en) | 2019-11-11 | 2021-05-20 | Firmenich Sa | Gingerol compounds and their use as flavor modifiers |
CN114727633A (en) | 2019-12-13 | 2022-07-08 | 弗门尼舍公司 | Taste-improving composition and use thereof |
WO2021118864A1 (en) | 2019-12-13 | 2021-06-17 | Firmenich Incorporated | Taste modifying compositions and uses thereof |
EP4044827A1 (en) | 2019-12-18 | 2022-08-24 | Firmenich Incorporated | Taste modifying compositions and uses thereof |
US20230000122A1 (en) | 2019-12-18 | 2023-01-05 | Firmenich Incorporated | Taste modifying compositions and uses thereof |
CN111170960B (en) * | 2020-01-17 | 2022-04-15 | 东莞波顿香料有限公司 | Meat flavor compound, preparation method thereof and flavor additive |
WO2021198199A1 (en) | 2020-03-31 | 2021-10-07 | Firmenich Sa | Flavor composition |
CN114096515A (en) | 2020-04-17 | 2022-02-25 | 弗门尼舍有限公司 | Amino acid derivatives and their use as flavor modifiers |
BR112022016262A2 (en) | 2020-05-22 | 2022-10-25 | Firmenich & Cie | COMPOSITIONS TO REDUCE SALTY TASTE AND USE OF THEM |
WO2021243273A1 (en) * | 2020-05-29 | 2021-12-02 | Taxis Pharmaceuticals, Inc. | Bacterial efflux pump inhibitors |
WO2021244953A1 (en) | 2020-06-03 | 2021-12-09 | Firmenich Sa | Compositions for reducing off tastes and uses thereof |
WO2021259945A1 (en) | 2020-06-24 | 2021-12-30 | Firmenich Sa | Sweetening compositions and uses thereof |
CN115551598A (en) | 2020-07-14 | 2022-12-30 | 弗门尼舍有限公司 | Reduction of undesirable taste profile in oral care products |
CN116322366A (en) * | 2020-07-24 | 2023-06-23 | 弗门尼舍公司 | Deliciousness enhancement by transmembrane domain binding |
US20230338247A1 (en) | 2020-09-22 | 2023-10-26 | Firmenich Sa | Wintergreen flavor compositions free of methyl salicylate |
US20230329299A1 (en) | 2020-10-13 | 2023-10-19 | Firmenich Sa | Malonyl steviol glycosides and their comestible use |
US20230345986A1 (en) | 2020-10-27 | 2023-11-02 | Firmenich Sa | Conjugated diynes and their use as flavor modifiers |
US20240036041A1 (en) | 2020-11-24 | 2024-02-01 | Firmenich Incorporated | Kokumi taste enhancement and related screening methods |
US20240000120A1 (en) | 2020-11-29 | 2024-01-04 | Firmenich Sa | Compositions that reduce peroxide off taste and uses thereof |
EP4213636A1 (en) | 2020-12-23 | 2023-07-26 | Firmenich SA | Uses of fat blends and emulsions thereof |
WO2022148540A1 (en) | 2021-01-08 | 2022-07-14 | Symrise Ag | Novel compositions for sour taste balancing |
EP4251122A1 (en) | 2021-01-13 | 2023-10-04 | Firmenich Incorporated | Compositions that enhance the cooling effect |
JP2024503100A (en) | 2021-01-15 | 2024-01-24 | フィルメニッヒ インコーポレイテッド | Sweetener compositions containing cyamenoside I and uses thereof |
WO2022155669A1 (en) | 2021-01-15 | 2022-07-21 | Firmenich Incorporated | Sweetener compositions comprising mogrosides and uses thereof |
EP4258897A1 (en) | 2021-01-15 | 2023-10-18 | Firmenich Incorporated | Sweetener compositions comprising mogrosides and uses thereof |
WO2022171569A1 (en) | 2021-02-10 | 2022-08-18 | Firmenich Sa | Fiber blends, sweetened fiber blends, and their comestible use |
WO2022189155A1 (en) | 2021-03-09 | 2022-09-15 | Firmenich Sa | Hydroxy- and methoxy-substituted flavones and their use |
US20240099344A1 (en) | 2021-03-09 | 2024-03-28 | Firmenich Sa | Hydroxy- and methoxy-substituted flavonoids and their use |
US20240099343A1 (en) | 2021-04-06 | 2024-03-28 | Firmenich Sa | Use of gingerdiol compounds to enhance flavor |
EP4307921A1 (en) | 2021-04-26 | 2024-01-24 | Firmenich Incorporated | Amide compounds and their use as flavor modifiers |
WO2022231908A1 (en) | 2021-04-26 | 2022-11-03 | Firmenich Incorporated | Amide compounds and their use as flavor modifiers |
WO2022238249A2 (en) | 2021-05-11 | 2022-11-17 | Firmenich Sa | Process of making gingerol compounds and their use as flavor modifiers |
EP4307910A1 (en) | 2021-05-24 | 2024-01-24 | Firmenich SA | Flavored fiber blends and their comestible use |
WO2022251628A1 (en) | 2021-05-28 | 2022-12-01 | Firmenich Incorporated | Compositions that enhance the cooling effect |
BR112023022013A2 (en) | 2021-06-02 | 2023-12-26 | Firmenich & Cie | DEACETYLATION PROCESS, COMPOSITIONS AND USES THEREOF |
WO2022268875A1 (en) | 2021-06-23 | 2022-12-29 | Firmenich Sa | Flavor-modifying compositions containing lactase |
BR112023026922A2 (en) | 2021-06-28 | 2024-03-05 | Firmenich Incorporated | POLYCATIONIC SALTS OF PHENOLIC COMPOUNDS AND USES THEREOF |
EP4333645A1 (en) | 2021-06-29 | 2024-03-13 | Firmenich Incorporated | Mogroside compounds and their comestible use |
CN117651498A (en) | 2021-06-29 | 2024-03-05 | 弗门尼舍有限公司 | Glycyrrhiza compounds and their use as flavor modifiers |
WO2023049308A1 (en) | 2021-09-27 | 2023-03-30 | Firmenich Incorporated | Use of vanillyl ethers to modify flavor of distilled spirits |
WO2023046914A1 (en) | 2021-09-27 | 2023-03-30 | Firmenich Sa | Flavor compositions containing iron compounds and their use |
WO2023072604A1 (en) | 2021-11-01 | 2023-05-04 | Firmenich Sa | Composition comprising a nutrient and a taste modulator |
WO2023107904A1 (en) | 2021-12-07 | 2023-06-15 | Firmenich Incorporated | Reduction of bitter taste of plant proteins and related assays and screening methods |
WO2023118002A1 (en) | 2021-12-20 | 2023-06-29 | Firmenich Sa | Encapsulated metal compounds and comestible uses thereof |
WO2023117643A1 (en) | 2021-12-23 | 2023-06-29 | Firmenich Sa | Antimicrobial composition having encapsulated colorant |
CN114264766B (en) * | 2021-12-31 | 2022-08-16 | 江苏艾兰得营养品有限公司 | Evaluation method of sweet orange essence for VC soft sweets |
WO2023172415A1 (en) | 2022-03-07 | 2023-09-14 | Firmenich Incorporated | Sweetener compositions |
WO2023169995A1 (en) | 2022-03-10 | 2023-09-14 | Firmenich Sa | Sweetener compositions |
WO2023172394A1 (en) | 2022-03-11 | 2023-09-14 | Firmenich Incorporated | Flavanone compounds and their use as flavor modifiers |
WO2023180063A1 (en) | 2022-03-25 | 2023-09-28 | Firmenich Sa | Fatty acid amides and their use as flavor modifiers |
WO2023186792A1 (en) | 2022-03-28 | 2023-10-05 | Firmenich Sa | Non-animal protein compositions and uses thereof |
WO2023196128A1 (en) | 2022-04-06 | 2023-10-12 | Firmenich Incorporated | Taste modifying compositions and uses thereof |
WO2023198436A2 (en) | 2022-04-11 | 2023-10-19 | Firmenich Sa | Sweetener compositions |
WO2023224812A1 (en) | 2022-05-16 | 2023-11-23 | Firmenich Incorporated | Unsaturated fatty acids and their use to modify taste |
WO2023224814A1 (en) | 2022-05-16 | 2023-11-23 | Firmenich Incorporated | Saturated fatty acids and their use to modify taste |
WO2023232968A1 (en) | 2022-06-03 | 2023-12-07 | Firmenich Sa | Fat reduction in non-animal protein compositions |
WO2023242177A1 (en) | 2022-06-14 | 2023-12-21 | Firmenich Sa | Polyelectrolyte complexes of proteins and uses thereof |
WO2023247332A1 (en) | 2022-06-24 | 2023-12-28 | Firmenich Sa | Taste modifying compositions and uses thereof |
WO2024011086A1 (en) | 2022-07-07 | 2024-01-11 | Firmenich Incorporated | Compositions that enhance the cooling effect |
WO2024041974A1 (en) | 2022-08-22 | 2024-02-29 | Firmenich Sa | Gel compositions and their use in seafood analogue products |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6383778B1 (en) * | 1998-07-28 | 2002-05-07 | The Regents Of The University Of California | Nucleic acids encoding a G-protein coupled receptor involved in sensory transduction |
US20030232407A1 (en) * | 2001-03-07 | 2003-12-18 | Senomyx, Inc. | T1R hetero-oligomeric taste receptors and cell lines that express said receptors and use thereof for identification of taste compounds |
Family Cites Families (209)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US415052A (en) * | 1889-11-12 | And samuel j | ||
US2987544A (en) | 1961-06-06 | Tranquilizers | ||
BE418027A (en) | 1935-10-22 | |||
GB502680A (en) | 1936-10-10 | 1939-03-21 | Du Pont | Improvements in or relating to the isolation of boron fluoride |
US2510945A (en) * | 1945-04-24 | 1950-06-13 | Us Agriculture | Nu-cyclohexyl nicotinamide |
US2519408A (en) * | 1946-10-09 | 1950-08-22 | Schering Corp | Antispasmodics |
NL93099C (en) * | 1953-04-16 | |||
GB858333A (en) * | 1956-10-05 | 1961-01-11 | Unilever Ltd | Flavouring substances and their preparation |
US3098693A (en) | 1960-05-27 | 1963-07-23 | Little Inc A | Treatment of protein and peptide materials to form amide linkages |
US3492323A (en) * | 1963-08-21 | 1970-01-27 | Hoffmann La Roche | N-(2-propynyloxy)-sulfanilamides |
US3281330A (en) | 1964-03-20 | 1966-10-25 | Upjohn Co | Microbiological process for the oxygenation of cycloalkanes |
US3294544A (en) | 1964-11-06 | 1966-12-27 | Richardson Merrell Inc | Artificial sweetener-arabinogalactan composition and edible foodstuff utilizing same |
NL129208C (en) * | 1965-07-14 | |||
GB1193289A (en) | 1965-07-14 | 1970-05-28 | Science Union & Cie | New Isoindolino-Sulphonylurea Derivatives and Process for Preparing them |
NL131479C (en) * | 1966-04-20 | |||
US3398155A (en) * | 1966-05-31 | 1968-08-20 | Abbott Lab | 2, 6-dichloro-isonicotinamide derivatives and a method for their preparation |
DE1695428C3 (en) * | 1967-06-08 | 1978-10-05 | Merck Patent Gmbh, 6100 Darmstadt | Derivatives of 5-mercaptopyridoxine and process for their preparation |
US4136163A (en) * | 1971-02-04 | 1979-01-23 | Wilkinson Sword Limited | P-menthane carboxamides having a physiological cooling effect |
US4150052A (en) | 1971-02-04 | 1979-04-17 | Wilkinson Sword Limited | N-substituted paramenthane carboxamides |
US4021224A (en) * | 1971-12-09 | 1977-05-03 | Stauffer Chemical Company | Herbicide compositions |
US4034109A (en) | 1973-01-18 | 1977-07-05 | Wilkinson Sword Limited | Compounds having a physiological cooling effect and compositions containing them |
US4177279A (en) * | 1973-10-10 | 1979-12-04 | John Wyeth & Brother Ltd. | 1-[(3-Indolyl)-alkyl]-piperidyl ureas and hypotensive compositions |
JPS5329211Y2 (en) | 1973-10-15 | 1978-07-22 | ||
JPS5716973B2 (en) | 1973-10-17 | 1982-04-08 | ||
GB1457671A (en) | 1974-01-31 | 1976-12-08 | Wilkinson Sword Ltd | Flavour |
GB1489359A (en) | 1974-12-11 | 1977-10-19 | Wilkinson Sword Ltd | Alicyclic carboxamides having physiological cooling activity |
US3944082A (en) | 1974-12-20 | 1976-03-16 | Harnischfeger Corporation | Locking means for relatively movable boom sections of boom of mobile crane |
JPS51106736A (en) * | 1975-03-14 | 1976-09-21 | Rikagaku Kenkyusho | NOENGEI YOSATSUKINZAI |
US3988510A (en) * | 1975-05-29 | 1976-10-26 | International Flavors & Fragrances Inc. | 3-Furyl sulfides and foodstuff flavor compositions comprising same |
GB1502680A (en) | 1975-06-03 | 1978-03-01 | Wilkinson Sword Ltd | Compositions for application to or consumption by the human body and containing compounds having a physiological cooling effect |
JPS5825980B2 (en) * | 1976-02-12 | 1983-05-31 | ヤマサ醤油株式会社 | Cyclic nucleotide quantification method |
US4049717A (en) | 1976-05-13 | 1977-09-20 | American Cyanamid Company | Novel 1,2,3,4-tetrahydro-4-oxo-(oxy)-1-naphthylamines and method of preparation thereof |
US4332724A (en) | 1976-08-12 | 1982-06-01 | American Cyanamid Co. | Process for preparing 4,5,6,7-tetrahydro-7-oxobenzo[b]thiophenes and 1,2,3,4-tetrahydro-4-oxonaphthalenes |
EP0005501B1 (en) | 1978-05-20 | 1981-11-25 | Bayer Ag | Heteroaryloxy-acetamides, process for their preparation and their use as herbicides |
US4535084A (en) | 1979-10-15 | 1985-08-13 | Pfizer Inc. | Certain 4-(2-hydroxyethylthiomethyl)pyridines and derivatives thereof having immunoregulatory activity |
US4535081A (en) | 1979-11-23 | 1985-08-13 | Pfizer Inc. | Antiallergic and antiulcer 1-oxo-1H-thiazolo[3,2-a]pyrimidine-2-carboxamides and intermediates therefor |
US4391904A (en) * | 1979-12-26 | 1983-07-05 | Syva Company | Test strip kits in immunoassays and compositions therein |
US4458066A (en) * | 1980-02-29 | 1984-07-03 | University Patents, Inc. | Process for preparing polynucleotides |
US4376110A (en) * | 1980-08-04 | 1983-03-08 | Hybritech, Incorporated | Immunometric assays using monoclonal antibodies |
US4366241A (en) * | 1980-08-07 | 1982-12-28 | Syva Company | Concentrating zone method in heterogeneous immunoassays |
EP0055689B1 (en) | 1980-12-22 | 1984-07-04 | Schering Aktiengesellschaft | 3-substituted 2,4,6-trihalogenobenzamides and their salts, their preparation and their use as substitutes for natural sweetening agents, and sweeteners containing them |
US4517288A (en) * | 1981-01-23 | 1985-05-14 | American Hospital Supply Corp. | Solid phase system for ligand assay |
DE3216843C2 (en) * | 1982-05-05 | 1986-10-23 | Ludwig Heumann & Co GmbH, 8500 Nürnberg | 3-Thiomethyl-pyridine derivatives, processes for their preparation and pharmaceuticals containing these compounds |
FR2533210A1 (en) * | 1982-09-17 | 1984-03-23 | Lyon I Universite Claude | SWEETENERS OF SYNTHESIS |
GB8309855D0 (en) * | 1983-04-12 | 1983-05-18 | Tate & Lyle Plc | Flavour modifiers |
US4571345A (en) * | 1983-06-13 | 1986-02-18 | Cumberland Packing Corp. | 1,1-Diaminoalkane derived sweeteners |
US5476849A (en) * | 1984-03-19 | 1995-12-19 | The Rockefeller University | Methods for glycosylation inhibition using amino-benzoic acids and derivatives |
FR2573087B1 (en) * | 1984-11-09 | 1987-07-10 | Inst Francais Du Petrole | METHOD OF SOFTENING OIL CUTTINGS CARRIED OUT IN THE ABSENCE OF AN ALKALINE COMPOUND |
IL76842A0 (en) | 1984-12-28 | 1986-02-28 | Monsanto Co | Novel n-acyl-n-isopropyl-glycine derivatives |
JPS61200951A (en) * | 1985-03-01 | 1986-09-05 | Kyowa Hakko Kogyo Co Ltd | Cyclopentanecarboxylic acid derivative |
US5506337A (en) * | 1985-03-15 | 1996-04-09 | Antivirals Inc. | Morpholino-subunit combinatorial library and method |
US4683202A (en) * | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
US4683195A (en) * | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
JPS61200951U (en) | 1985-06-04 | 1986-12-16 | ||
JPS6181858A (en) | 1985-08-09 | 1986-04-25 | Honda Motor Co Ltd | Vehicle antilock barking device |
CA1291031C (en) * | 1985-12-23 | 1991-10-22 | Nikolaas C.J. De Jaeger | Method for the detection of specific binding agents and their correspondingbindable substances |
US4835181A (en) | 1987-02-18 | 1989-05-30 | Eli Lilly And Company | Anticonvulsant agents using cyano dimethylphenyl benzamides |
JPH0784428B2 (en) * | 1987-10-19 | 1995-09-13 | 鐘淵化学工業株式会社 | Dipeptide derivative and sweetener containing the same |
FR2624699B1 (en) * | 1987-12-18 | 1990-04-13 | Bernard Lyon I Universite Clau | HETEROCYCLIC DERIVATIVES OF N-CARBAMOYL-, N-THIOCARBAMOYL- OR N-AMIDINO-GLYCINE OR BETA-ALANINE USEFUL AS SWEETENING AGENTS |
US5010175A (en) * | 1988-05-02 | 1991-04-23 | The Regents Of The University Of California | General method for producing and selecting peptides with specific properties |
US5176928A (en) * | 1988-08-04 | 1993-01-05 | The Nutrasweet Company | Reduced calorie diary mix |
JPH02108697A (en) * | 1988-10-15 | 1990-04-20 | Kanegafuchi Chem Ind Co Ltd | Dipeptide derivative and peptide sweetener containing the same |
US4910031A (en) | 1988-12-19 | 1990-03-20 | Frito-Lay, Inc. | Topped savory snack foods |
JPH02108697U (en) | 1989-02-17 | 1990-08-29 | ||
US5001115A (en) | 1989-05-17 | 1991-03-19 | University Of Florida | Prodrugs of biologically active hydroxyaromatic compounds |
DE3916430A1 (en) | 1989-05-20 | 1990-11-22 | Bayer Ag | METHOD FOR PRODUCING 3-AMINO-5-AMINOCARBONYL-1,2,4-TRIAZOLE DERIVATIVES |
CA2020887A1 (en) | 1989-07-28 | 1991-01-29 | Michael Klaus | Aromatic carboxylic amides |
US5147463A (en) | 1989-08-18 | 1992-09-15 | Basf K&F Corporation | Cyclic acetals |
US5464764A (en) * | 1989-08-22 | 1995-11-07 | University Of Utah Research Foundation | Positive-negative selection methods and vectors |
US5057601A (en) | 1989-11-06 | 1991-10-15 | Olin Corporation | Process for producing a gel-free coagulated rubber with low ethylenic unsaturation |
US5021249A (en) | 1989-11-09 | 1991-06-04 | Warner-Lambert Company | Method of making a savory flavor granule and a free flowing savory flavor granule |
EP0779362B2 (en) | 1989-12-22 | 2012-06-13 | Laboratoires Serono SA | DNA constructs for endogenous gene activation and expression modification |
US5272071A (en) * | 1989-12-22 | 1993-12-21 | Applied Research Systems Ars Holding N.V. | Method for the modification of the expression characteristics of an endogenous gene of a given cell line |
WO1991012650A1 (en) | 1990-02-09 | 1991-08-22 | Asulab S.A. | Electrostatic radial field micromotor obtained by photolithographic micromanufacture and method of manufacture thereof |
JP2933975B2 (en) | 1990-04-26 | 1999-08-16 | 長谷川香料株式会社 | How to enhance the sweetness of food and drink |
IE66205B1 (en) | 1990-06-14 | 1995-12-13 | Paul A Bartlett | Polypeptide analogs |
US5650489A (en) | 1990-07-02 | 1997-07-22 | The Arizona Board Of Regents | Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof |
HUT65903A (en) | 1990-07-10 | 1994-07-28 | Smithkline Beecham Corp | Oxamides, process for preparing them and pharmaceutical compositions containing them |
US5401629A (en) * | 1990-08-07 | 1995-03-28 | The Salk Institute Biotechnology/Industrial Associates, Inc. | Assay methods and compositions useful for measuring the transduction of an intracellular signal |
US5508407A (en) * | 1991-07-10 | 1996-04-16 | Eli Lilly And Company | Retroviral protease inhibitors |
US5641670A (en) | 1991-11-05 | 1997-06-24 | Transkaryotic Therapies, Inc. | Protein production and protein delivery |
US6270989B1 (en) | 1991-11-05 | 2001-08-07 | Transkaryotic Therapies, Inc. | Protein production and delivery |
NZ245015A (en) | 1991-11-05 | 1995-12-21 | Transkaryotic Therapies Inc | Delivery of human growth hormone through the administration of transfected cell lines encoding human growth hormone, which are physically protected from host immune response; the transfected cells and their production |
FR2684670B1 (en) * | 1991-12-05 | 1995-04-07 | Commissariat Energie Atomique | AMIDES WITH NITROGEN HETEROCYCLIC SUBSTITUTES, PROCESS FOR THEIR PREPARATION AND THEIR USE FOR SELECTIVELY EXTRACTING ACTINIDES (III) AND PARTICULARLY LANTHANIDES (III). |
US5573905A (en) | 1992-03-30 | 1996-11-12 | The Scripps Research Institute | Encoded combinatorial chemical libraries |
US5283722A (en) | 1992-08-05 | 1994-02-01 | Koenen Howard P | Surgical-type glove and illuminator assembly |
US5288514A (en) * | 1992-09-14 | 1994-02-22 | The Regents Of The University Of California | Solid phase and combinatorial synthesis of benzodiazepine compounds on a solid support |
US6664107B1 (en) * | 1993-05-26 | 2003-12-16 | Ontario Cancer Institute, University Health Network | CD45 disrupted nucleic acid |
US5426039A (en) * | 1993-09-08 | 1995-06-20 | Bio-Rad Laboratories, Inc. | Direct molecular cloning of primer extended DNA containing an alkane diol |
US5547966A (en) | 1993-10-07 | 1996-08-20 | Bristol-Myers Squibb Company | Aryl urea and related compounds |
CA2138929A1 (en) * | 1993-12-30 | 1995-07-01 | Klaus Weidmann | Substituted heterocyclic carboxamides, their preparation and their use as pharmaceuticals |
US5914349A (en) | 1994-01-10 | 1999-06-22 | Teva Pharmaceutical Industries, Ltd. | Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives |
AU1867095A (en) | 1994-01-10 | 1995-08-01 | Technion Research & Development Foundation Ltd. | 1-aminoindan derivatives and compositions thereof |
US5519134A (en) * | 1994-01-11 | 1996-05-21 | Isis Pharmaceuticals, Inc. | Pyrrolidine-containing monomers and oligomers |
US5593853A (en) * | 1994-02-09 | 1997-01-14 | Martek Corporation | Generation and screening of synthetic drug libraries |
US5691188A (en) * | 1994-02-14 | 1997-11-25 | American Cyanamid Company | Transformed yeast cells expressing heterologous G-protein coupled receptor |
US5539083A (en) * | 1994-02-23 | 1996-07-23 | Isis Pharmaceuticals, Inc. | Peptide nucleic acid combinatorial libraries and improved methods of synthesis |
US5522175A (en) * | 1994-06-01 | 1996-06-04 | Biosource Technologies, Inc. | Natural savory and umami flavoring materials from dehydrated mushroom |
US5525735A (en) * | 1994-06-22 | 1996-06-11 | Affymax Technologies Nv | Methods for synthesizing diverse collections of pyrrolidine compounds |
US5549974A (en) * | 1994-06-23 | 1996-08-27 | Affymax Technologies Nv | Methods for the solid phase synthesis of thiazolidinones, metathiazanones, and derivatives thereof |
JPH08103243A (en) * | 1994-10-06 | 1996-04-23 | T Hasegawa Co Ltd | Sustainable flavor/scent imparting agent |
DE69530067T2 (en) * | 1994-10-07 | 2004-01-29 | Firmenich & Cie | AROMA COMPOSITION AND FLAVORING METHOD |
US5801195A (en) | 1994-12-30 | 1998-09-01 | Celgene Corporation | Immunotherapeutic aryl amides |
ZA96211B (en) | 1995-01-12 | 1996-07-26 | Teva Pharma | Compositions containing and methods of using 1- aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives |
GB2334822B (en) | 1995-04-10 | 1999-10-20 | Otter Controls Ltd | Thermal control for liquid heating vessels |
BR9608688A (en) | 1995-05-31 | 1999-07-06 | Kumiai Vhemical Industry Co Lt | Derivatives of phenylalkane amide and agricultural and horticultural fungicides |
EP0831854A4 (en) | 1995-06-06 | 2001-01-24 | Isis Pharmaceuticals Inc | Oligonucleotides having phosphorothioate linkages of high chiral purity |
US5977322A (en) | 1995-06-14 | 1999-11-02 | The Regents Of The University Of California | High affinity human antibodies to tumor antigens |
US5985662A (en) | 1995-07-13 | 1999-11-16 | Isis Pharmaceuticals Inc. | Antisense inhibition of hepatitis B virus replication |
EP0783253B1 (en) * | 1995-07-26 | 2002-10-23 | Firmenich Sa | Flavoured products and method for preparing same |
US6133317A (en) | 1995-11-15 | 2000-10-17 | Hart; Francis J. | Oxalic acid or oxalate composition and method of treatment |
KR19990082330A (en) | 1996-02-06 | 1999-11-25 | 미즈노 마사루 | Novel compounds and uses thereof |
US6211364B1 (en) * | 1997-01-22 | 2001-04-03 | Eli Lilly And Company | Process for preparing indane-like compounds |
JP3573757B2 (en) | 1997-01-29 | 2004-10-06 | ファイザー・インク | Sulfonylurea derivatives and use of the sulfonylurea derivatives in controlling interleukin-1 activity |
WO2004096919A1 (en) | 1997-04-07 | 2004-11-11 | Masahiro Suzuki | Resin composition and adhesive film |
AR013079A1 (en) | 1997-05-06 | 2000-12-13 | Smithkline Beecham Corp | SUBSTITUTED DERIVATIVES OF TETRAHIDROFURANO-3-ONAS, TETRAHIDROPIRANO-3- ONAS AND TETRAHIDROTIOFEN-3-ONAS, A PROCEDURE FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION OF A MEDICINAL PRODUCT USEFUL AS INTERMEDIATE PROTEIN INHIBITORS |
US5945441A (en) | 1997-06-04 | 1999-08-31 | Gpi Nil Holdings, Inc. | Pyrrolidine carboxylate hair revitalizing agents |
MY119059A (en) | 1997-08-11 | 2005-03-31 | Cadbury Adams Usa Llc | Enhanced flavoring compositions containing n-ethyl-p-menthane-3-carboxamide and method of making and using same |
WO1999021543A1 (en) * | 1997-10-27 | 1999-05-06 | Sumitomo Pharmaceuticals Co., Ltd. | Amide derivatives |
CA2311131A1 (en) | 1997-11-21 | 1999-06-03 | Nps Pharmaceuticals, Inc. | Metabotropic glutamate receptor antagonists for treating central nervous system diseases |
US6429207B1 (en) | 1997-11-21 | 2002-08-06 | Nps Pharmaceuticals, Inc. | Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases |
US6432454B1 (en) | 1997-12-12 | 2002-08-13 | C. V. Technologies, Inc. | Processes of making north american ginseng fractions, products containing them, and use as immunomodulators |
DE69907402T2 (en) | 1998-01-05 | 2003-11-13 | Arla Foods Amba Viby J | USE OF T-TAGATOSE AS A SYNERGIST AND TASTE AMPLIFIER |
DE19808261A1 (en) * | 1998-02-27 | 1999-10-28 | Bayer Ag | Arylphenyl substituted cyclic ketoenols |
DE19818732A1 (en) | 1998-04-27 | 1999-10-28 | Bayer Ag | New aryl substituted cyclic ketoenol compounds useful for control of insects and as herbicides |
US7402400B2 (en) * | 2001-07-03 | 2008-07-22 | Regents Of The University Of California | Mammalian sweet taste receptors |
AU753703B2 (en) | 1998-07-28 | 2002-10-24 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Nucleic acids encoding a G-protein coupled receptor involved in sensory transduction |
US7588900B2 (en) * | 2001-07-03 | 2009-09-15 | The Regents Of The University Of California | Mammalian sweet and amino acid heterodimeric taste receptors |
US6617351B1 (en) | 1998-07-31 | 2003-09-09 | Eli Lilly And Company | Amide, carbamate, and urea derivatives |
PE20000942A1 (en) | 1998-07-31 | 2000-09-28 | Lilly Co Eli | DERIVATIVES OF AMIDE, CARBAMATE AND UREA |
JP2000169438A (en) | 1998-10-02 | 2000-06-20 | Kumiai Chem Ind Co Ltd | Arylacetamide derivative and agricultural and horticultural germicide |
US6399731B2 (en) | 1998-10-08 | 2002-06-04 | The University Of Akron | Chain transfer agents and its use in polymer synthesis |
EP1134214A4 (en) * | 1998-11-04 | 2004-12-15 | Meiji Seika Kaisha | Picolinamide derivatives and pest controllers containing the same as the active ingredient |
AUPP891299A0 (en) | 1999-02-26 | 1999-03-25 | Fujisawa Pharmaceutical Co., Ltd. | New 6-membered cyclic compounds |
US6248363B1 (en) * | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
US6362165B1 (en) * | 1999-03-30 | 2002-03-26 | Pharmacor Inc. | Hydroxyphenyl derivatives with HIV integrase inhibitory properties |
TW593241B (en) | 1999-04-20 | 2004-06-21 | Hoffmann La Roche | Carbamic acid derivatives |
WO2000069283A1 (en) * | 1999-05-13 | 2000-11-23 | The Nutrasweet Company | USE OF ADDITIVES TO MODIFY THE TASTE CHARACTERISTICS OF N-NEOHEXYL-α-ASPARTYL-L-PHENYLALANINE METHYL ESTER |
KR100743262B1 (en) * | 1999-07-20 | 2007-07-27 | 다우 아그로사이언시즈 엘엘씨 | Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
US6463445B1 (en) | 1999-08-27 | 2002-10-08 | Sony Electronics Inc. | Multimedia information retrieval system and method including format conversion system and method |
WO2001035768A1 (en) | 1999-11-15 | 2001-05-25 | J.Manheimer, Inc. | Flavor freshness enhancers |
AU2001228811A1 (en) * | 2000-01-26 | 2001-08-07 | Ono Pharmaceutical Co. Ltd. | Nitrogen-containing 5-membered cyclic compounds and drugs containing these compounds as the active ingredient |
JP3587361B2 (en) | 2000-01-27 | 2004-11-10 | キヤノン株式会社 | Organic light emitting device |
JP3112457B2 (en) | 2000-03-01 | 2000-11-27 | 曽田香料株式会社 | Sweetness enhancer |
TW201006846A (en) * | 2000-03-07 | 2010-02-16 | Senomyx Inc | T1R taste receptor and genes encidung same |
US6608176B2 (en) * | 2000-03-31 | 2003-08-19 | University Of Miami | Taste receptor for umami (monosodium glutamate) taste |
EP1692952A3 (en) | 2000-04-06 | 2006-10-25 | Quest International B.V. | Flavouring a foodstuff with compounds containing a sulphur atom linked to two specific atoms or groups |
WO2001077292A2 (en) | 2000-04-07 | 2001-10-18 | Senomyx, Inc. | Novel signal transduction molecules |
AU5125801A (en) | 2000-04-07 | 2001-10-23 | Senomyx Inc | T2r taste receptors and genes encoding same |
DE10019145A1 (en) | 2000-04-18 | 2001-10-25 | Bayer Ag | New phenyl substituted 4-hydroxy-tetrahydropyridone derivatives useful for control of animal pests and as herbicides |
DE10021246A1 (en) | 2000-04-25 | 2001-10-31 | Schering Ag | New N-substituted benzamide derivatives are tyrosine kinase KDR and FLT inhibitors useful e.g. for treating tumors, psoriasis, rheumatoid arthritis, diabetic retinopathy or liver sclerosis |
CN1234358C (en) | 2000-06-21 | 2006-01-04 | 弗·哈夫曼-拉罗切有限公司 | Benzothiazole derivatives |
US7374878B2 (en) | 2000-06-22 | 2008-05-20 | Senomyx, Inc. | Receptor fingerprinting, sensory perception, and biosensors of chemical sensants |
DE10030891A1 (en) * | 2000-06-23 | 2002-01-03 | Haarmann & Reimer Gmbh | New 3,4-dihydroxybenzyl-substituted carbonic acid derivatives are antioxidants and radical scavengers useful e.g. for preventing skin aging or protecting cosmetic, dermatological or foodstuff compositions against oxidation |
US6399641B1 (en) | 2000-07-13 | 2002-06-04 | Hoffmann-La Roche Inc. | 2H-tetrazole-amide compounds with therapeutic activity as metabotropic glutamate receptor agonists |
US7041457B2 (en) | 2000-10-30 | 2006-05-09 | Senomyx, Inc. | Gαq protein variants and their use in the analysis and discovery of agonists and antagonists of chemosensory receptors |
WO2002036622A2 (en) | 2000-10-30 | 2002-05-10 | Senomyx, Inc. | GαqPROETIN VARIANTS AND THEIR USE IN THE ANALYSIS AND DISCOVERY OF AGONISTS AND ANTAGONISTS OF CHEMOSENSORY RECEPTORS |
US6365215B1 (en) | 2000-11-09 | 2002-04-02 | International Flavors & Fragrances Inc. | Oral sensory perception-affecting compositions containing dimethyl sulfoxide, complexes thereof and salts thereof |
JP3744791B2 (en) | 2000-12-01 | 2006-02-15 | 株式会社リコー | Toner recycling apparatus and electrophotographic image forming apparatus having the same |
TW201022287A (en) | 2001-01-03 | 2010-06-16 | Senomyx Inc | T1R taste receptors and genes encoding same |
JP2002234898A (en) * | 2001-02-08 | 2002-08-23 | Ajinomoto Co Inc | New n-alkylaspartyl dipeptide derivative and sweetener |
EP1361878A1 (en) | 2001-02-15 | 2003-11-19 | Neurosearch A/S | Treatment of parkinson's disease by the combined action of a compound with neurotrophic activity and a compound enhancing the dopamine activity |
DE10109856A1 (en) | 2001-03-01 | 2002-09-05 | Bayer Ag | Use of N-phenyl arylamide for treating or preventing chronic or acute hepatitis B viral infections in humans or animals, including co-infections with hepatitis D virus |
US6955887B2 (en) | 2001-03-30 | 2005-10-18 | Senomyx, Inc. | Use of T1R hetero-oligomeric taste receptor to screen for compounds that modulate taste signaling |
US7301009B2 (en) | 2001-06-26 | 2007-11-27 | Senomyx, Inc. | Isolated (T1R1/T1R3) umami taste receptors that respond to umami taste stimuli |
US7309577B2 (en) | 2001-03-07 | 2007-12-18 | Senomyx, Inc. | Binding assays that use the T1R1/T1R3 (umami) taste receptor to identify compounds that elicit or modulate umami taste |
DE10117823A1 (en) | 2001-04-10 | 2002-10-17 | Merck Patent Gmbh | New N-phenyl-oxalamide derivatives, are factor Xa and factor VIIa inhibitors useful e.g. for treating thrombosis, myocardial infarction, inflammation, angina pectoris or tumor diseases |
EP1389426A4 (en) * | 2001-04-25 | 2005-01-12 | Yakult Honsha Kk | Fermented foods and process for producing the same |
AU2002307434A1 (en) | 2001-04-25 | 2002-11-05 | Senomyx, Inc. | Use of low molecular weight acetal, alcohol, acylated alcohol and ester compounds to block or reduce odor of carboxylic acids |
EP1252825A1 (en) | 2001-04-25 | 2002-10-30 | Société des Produits Nestlé S.A. | Flavouring compositions |
WO2002087306A2 (en) | 2001-05-01 | 2002-11-07 | Senomyx, Inc. | High throughput cell-based assay for monitoring sodium channel activity and discovery of salty taste modulating compounds |
DK2327985T3 (en) * | 2001-06-26 | 2016-09-05 | Senomyx Inc | H1 Oligomeric T1R Taste Receptors and Cell Lines Expressing the Receptors, and Their Use to Identify Taste Compounds |
AU2002326315B2 (en) | 2001-06-26 | 2007-07-05 | Senomyx, Inc. | T1R hetero-oligomeric taste receptors and cell lines that express said receptors and use thereof for identification of taste compounds |
US7052857B2 (en) | 2001-07-06 | 2006-05-30 | Senomyx, Inc. | Expression of functional human olfactory cyclic nucleotide gated (CNG) channel in recombinant host cells and use thereof in cell based assays to identify GPCR modulators |
JP4551656B2 (en) | 2001-07-10 | 2010-09-29 | セノミックス インコーポレイテッド | Use of specific T2R taste receptors to identify compounds that block bitterness |
AU2002342607B2 (en) | 2001-08-06 | 2006-10-19 | Pharmacia Italia S.P.A. | Aminoisoxazole derivatives active as kinase inhibitors |
EP1291342A1 (en) * | 2001-09-06 | 2003-03-12 | Societe Des Produits Nestle S.A. | Pyridinium-betain compounds as taste enhancer |
US7326731B2 (en) * | 2001-09-21 | 2008-02-05 | Eli Lilly And Company | Muscarinic agonists |
JP4840837B2 (en) * | 2001-09-28 | 2011-12-21 | 日本たばこ産業株式会社 | Novel peptide having umami taste and seasoning containing umami ingredient |
JPWO2003030937A1 (en) * | 2001-10-05 | 2005-01-20 | 小野薬品工業株式会社 | A therapeutic agent for stress diseases comprising mitochondrial benzodiazepine receptor antagonists |
DE60208815T2 (en) | 2001-10-12 | 2006-07-20 | Bayer Pharmaceuticals Corp., West Haven | PHENYL SUBSTITUTES 5-LOW NITROGEN-CONTAINING HETEROCYCLES FOR THE TREATMENT OF FAT ADJUSTMENT |
GB0124941D0 (en) | 2001-10-17 | 2001-12-05 | Glaxo Group Ltd | Chemical compounds |
US7329426B2 (en) | 2001-11-13 | 2008-02-12 | Applied Food Biotechnology, Inc. | Treatment of vegetable oils or animal fats with sulfur or nitrogen donor compounds for animal food flavorings |
EP1312268A1 (en) | 2001-11-19 | 2003-05-21 | Société des Produits Nestlé S.A. | Flavouring compositions |
US7208290B2 (en) | 2001-12-14 | 2007-04-24 | Senomyx, Inc. | Methods of co-expressing umami taste receptors and chimeric Gα15 variants |
US7344845B2 (en) | 2001-12-21 | 2008-03-18 | Senomyx, Inc. | Olfactory receptor for isovaleric acid and related malodorants and use thereof in assays for identification of blockers of malodor |
EP1323356B1 (en) * | 2001-12-27 | 2006-03-15 | Symrise GmbH & Co. KG | Use of ferulic amides as flavouring agents |
US7057040B2 (en) | 2002-02-07 | 2006-06-06 | Council Of Scientific And Industrial Research | Substituted aryl alkenoic acid heterocyclic amides |
US6818772B2 (en) * | 2002-02-22 | 2004-11-16 | Abbott Laboratories | Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor |
BR0309522A (en) | 2002-04-26 | 2005-02-09 | Ishihara Sangyo Kaisha | Pyridine compounds or salts thereof and herbicides containing them |
AU2003242127A1 (en) | 2002-06-05 | 2003-12-22 | Institute Of Medicinal Molecular Design, Inc. | Inhibitors against the activation of ap-1 and nfat |
US20040006135A1 (en) | 2002-06-19 | 2004-01-08 | Pfizer Inc. | Combination treatment for depression and anxiety |
EP1572960A4 (en) | 2002-07-29 | 2009-03-18 | Senomyx Inc | Identification of a novel bitter taste receptor, t2r76 |
GB0221697D0 (en) | 2002-09-18 | 2002-10-30 | Unilever Plc | Novel compouds and their uses |
US7635709B2 (en) * | 2002-09-26 | 2009-12-22 | The United States Of America As Represented By The Department Of Veterans Affairs | Compositions and methods for bowel care in individuals with chronic intestinal pseudo-obstruction |
ATE368678T1 (en) | 2003-03-10 | 2007-08-15 | Nestec Sa | PYRIDINIUM BETAINE COMPOUNDS AND THEIR USE |
GB2415430B (en) | 2003-03-12 | 2006-07-12 | Kudos Pharm Ltd | Phthalazinone derivatives |
JP2006526623A (en) | 2003-04-08 | 2006-11-24 | フレキシトラル,インコーポレーテッド | Fragrance composition containing benzo [4,5] thieno [3,2b] pyran-2-one |
EP1615698B1 (en) | 2003-04-11 | 2010-09-29 | High Point Pharmaceuticals, LLC | New amide derivatives and pharmaceutical use thereof |
US20060094699A1 (en) * | 2003-04-11 | 2006-05-04 | Kampen Gita Camilla T | Combination therapy using an 11beta-hydroxysteroid dehydrogenase type 1 inhibitor and a glucocorticoid receptor agonist to minimize the side effects associated with glucocorticoid receptor agonist therapy |
WO2004113304A1 (en) | 2003-05-22 | 2004-12-29 | Abbott Laboratories | Indazole, benzisoxazole, and benzisothiazole kinase inhibitors |
EP3431464A3 (en) | 2003-08-06 | 2019-07-31 | Senomyx Inc. | Novel flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof |
US20060045953A1 (en) * | 2004-08-06 | 2006-03-02 | Catherine Tachdjian | Aromatic amides and ureas and their uses as sweet and/or umami flavor modifiers, tastants and taste enhancers |
US7191089B2 (en) | 2004-12-01 | 2007-03-13 | Freescale Semiconductor, Inc. | System and method for fall detection |
WO2006084245A2 (en) | 2005-02-03 | 2006-08-10 | Educational Testing Service | Method and system for detecting off-topic essays without topic-specific training |
JP4734346B2 (en) * | 2005-02-04 | 2011-07-27 | セノミックス インコーポレイテッド | Compounds containing linked heteroaryl moieties, and novel umami flavor modifiers, tastants and taste enhancers for edible compositions |
TW200638882A (en) | 2005-02-04 | 2006-11-16 | Senomyx Inc | Molecules comprising linked organic moieties as flavor modifiers for comestible compositions |
AR055329A1 (en) | 2005-06-15 | 2007-08-15 | Senomyx Inc | BIS-AROMATIC AMIDAS AND ITS USES AS SWEET FLAVORS, FLAVORS, AND FLAVOR ENHANCERS |
DK3235811T3 (en) | 2006-04-21 | 2018-11-12 | Senomyx Inc | PROCEDURE FOR THE PREPARATION OF OXALAMIDS |
-
2004
- 2004-08-06 EP EP18191450.8A patent/EP3431464A3/en active Pending
- 2004-08-06 MX MXPA06001510A patent/MXPA06001510A/en active IP Right Grant
- 2004-08-06 BR BRPI0413347-1A patent/BRPI0413347A/en not_active Application Discontinuation
- 2004-08-06 RU RU2006106919/04A patent/RU2419602C2/en active
- 2004-08-06 MY MYPI20043224A patent/MY174572A/en unknown
- 2004-08-06 NZ NZ627505A patent/NZ627505A/en not_active IP Right Cessation
- 2004-08-06 CA CA2900181A patent/CA2900181C/en not_active Expired - Fee Related
- 2004-08-06 JP JP2006522754A patent/JP2007512227A/en active Pending
- 2004-08-06 CA CA002535045A patent/CA2535045A1/en not_active Abandoned
- 2004-08-06 US US10/913,303 patent/US7476399B2/en active Active
- 2004-08-06 NZ NZ545747A patent/NZ545747A/en not_active IP Right Cessation
- 2004-08-06 EP EP04816798.5A patent/EP1659881B1/en active Active
- 2004-08-06 WO PCT/US2004/025419 patent/WO2005041684A2/en active Application Filing
- 2004-08-06 CN CN201310151776.9A patent/CN103275058B/en active Active
- 2004-08-06 SG SG200806053-5A patent/SG145745A1/en unknown
- 2004-08-06 AR ARP040102813A patent/AR046078A1/en not_active Application Discontinuation
- 2004-08-06 EP EP04780314A patent/EP1660859A4/en not_active Withdrawn
- 2004-08-06 SG SG200806054-3A patent/SG153714A1/en unknown
- 2004-08-06 RU RU2006106920/13A patent/RU2006106920A/en not_active Application Discontinuation
- 2004-08-06 NZ NZ597500A patent/NZ597500A/en not_active IP Right Cessation
- 2004-08-06 CA CA2535036A patent/CA2535036C/en not_active Expired - Fee Related
- 2004-08-06 US US10/569,870 patent/US20070104709A1/en not_active Abandoned
- 2004-08-06 AU AU2004285410A patent/AU2004285410B2/en not_active Ceased
- 2004-08-06 BR BRPI0413324-2A patent/BRPI0413324A/en not_active Application Discontinuation
- 2004-08-06 ES ES04816798T patent/ES2733577T3/en active Active
- 2004-08-06 JP JP2006522748A patent/JP5036310B2/en active Active
- 2004-08-06 WO PCT/US2004/025459 patent/WO2005015158A2/en active Application Filing
- 2004-08-06 NZ NZ545746A patent/NZ545746A/en not_active IP Right Cessation
- 2004-08-06 AU AU2004263871A patent/AU2004263871B2/en not_active Ceased
- 2004-08-06 NZ NZ619746A patent/NZ619746A/en not_active IP Right Cessation
- 2004-08-06 NZ NZ580418A patent/NZ580418A/en not_active IP Right Cessation
- 2004-08-06 CL CL200402015A patent/CL2004002015A1/en unknown
-
2006
- 2006-02-06 IL IL173551A patent/IL173551A/en active IP Right Grant
- 2006-02-06 IL IL173552A patent/IL173552A/en active IP Right Grant
- 2006-03-06 ZA ZA2006/01904A patent/ZA200601904B/en unknown
-
2007
- 2007-07-17 US US11/879,364 patent/US7888470B2/en active Active
- 2007-08-03 JP JP2007203679A patent/JP5036446B2/en active Active
- 2007-08-06 JP JP2007204822A patent/JP2008013570A/en active Pending
-
2008
- 2008-10-23 US US12/257,017 patent/US8124121B2/en active Active
-
2010
- 2010-04-01 RU RU2010112728/10A patent/RU2010112728A/en not_active Application Discontinuation
- 2010-08-09 US US12/852,941 patent/US8404455B2/en active Active
- 2010-09-02 IL IL207954A patent/IL207954A0/en unknown
-
2011
- 2011-03-31 AU AU2011201468A patent/AU2011201468C9/en not_active Ceased
- 2011-12-23 US US13/336,272 patent/US8895050B2/en active Active
-
2012
- 2012-03-12 US US13/417,660 patent/US8735081B2/en active Active
-
2013
- 2013-02-19 US US13/770,251 patent/US9091686B2/en active Active
-
2014
- 2014-09-04 US US14/477,027 patent/US9459250B2/en active Active
- 2014-10-08 US US14/509,761 patent/US10060909B2/en active Active
-
2015
- 2015-07-27 PH PH12015501666A patent/PH12015501666B1/en unknown
- 2015-07-27 PH PH12015501663A patent/PH12015501663A1/en unknown
- 2015-07-27 PH PH12015501667A patent/PH12015501667A1/en unknown
- 2015-07-27 PH PH12015501664A patent/PH12015501664A1/en unknown
- 2015-07-27 PH PH12015501665A patent/PH12015501665A1/en unknown
- 2015-07-27 PH PH12015501662A patent/PH12015501662B1/en unknown
-
2016
- 2016-06-30 PH PH12016501312A patent/PH12016501312A1/en unknown
- 2016-06-30 PH PH12016501311A patent/PH12016501311A1/en unknown
- 2016-08-23 US US15/244,135 patent/US10352929B2/en not_active Expired - Fee Related
- 2016-12-23 CL CL2016003325A patent/CL2016003325A1/en unknown
-
2018
- 2018-08-27 US US16/114,108 patent/US10557845B2/en active Active
-
2019
- 2019-06-11 US US16/437,049 patent/US20200049699A1/en not_active Abandoned
-
2020
- 2020-01-16 US US16/745,231 patent/US11268952B2/en active Active
-
2022
- 2022-02-23 US US17/678,512 patent/US20220326230A1/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6383778B1 (en) * | 1998-07-28 | 2002-05-07 | The Regents Of The University Of California | Nucleic acids encoding a G-protein coupled receptor involved in sensory transduction |
US20030232407A1 (en) * | 2001-03-07 | 2003-12-18 | Senomyx, Inc. | T1R hetero-oligomeric taste receptors and cell lines that express said receptors and use thereof for identification of taste compounds |
Non-Patent Citations (1)
Title |
---|
See also references of EP1660859A2 * |
Cited By (158)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7452685B2 (en) | 2000-03-07 | 2008-11-18 | Senomyx, Inc. | T1R1 receptor binding assays for identification of taste modulators |
US8816057B2 (en) | 2000-03-07 | 2014-08-26 | Senomyx, Inc. | T1R taste receptors and genes encoding same |
US7223551B2 (en) | 2000-03-07 | 2007-05-29 | Senomyx, Inc. | T1R3 receptor binding assays for identification of taste modulatory compounds |
US7244835B2 (en) | 2000-03-07 | 2007-07-17 | Senomyx, Inc. | T1R taste receptors and genes encoding same |
US9637536B2 (en) | 2000-03-07 | 2017-05-02 | Senomyx, Inc. | T1R taste receptors and genes encoding same |
US8314224B2 (en) | 2000-03-07 | 2012-11-20 | Senomyx, Inc. | T1R taste receptors and genes encoding same |
US8263341B2 (en) | 2000-03-07 | 2012-09-11 | Senomyx, Inc. | Assays that detect T1R expressing cells |
US8247542B2 (en) | 2000-03-07 | 2012-08-21 | Senomyx, Inc. | T1R3 nucleic acid fragments for use thereof as probes and for generating T1R specific antibodies |
US10093718B2 (en) | 2000-03-07 | 2018-10-09 | Senomyx, Inc. | T1R taste receptors and genes encoding same |
US7847080B2 (en) | 2000-03-07 | 2010-12-07 | Senomyx, Inc. | Chimeric T1R1 taste receptor encoding nucleic acid sequences and vectors |
US7842785B2 (en) | 2000-03-07 | 2010-11-30 | Senomyx, Inc. | Chimeric human T1R1 taste receptor polypeptides and compositions containing same |
US7799905B2 (en) | 2000-03-07 | 2010-09-21 | Senomyx, Inc. | T1R1 nucleic acid sequences and vectors containing same |
US7790848B2 (en) | 2000-03-07 | 2010-09-07 | Senomyx, Inc. | T1R3 receptor binding assays for identification of T1R3 modulatory compounds |
US7772385B2 (en) | 2000-03-07 | 2010-08-10 | Senomyx, Inc. | Chimeric T1R1 taste receptor encoding nucleic acid sequences and vectors |
US7737254B2 (en) | 2000-03-07 | 2010-06-15 | Senomyx, Inc. | Chimeric human T1R1 taste receptor polypeptides and compositions containing same |
US7705121B2 (en) | 2000-03-07 | 2010-04-27 | Senomyx, Inc. | Chimeric human T1R3 taste receptor polypeptides and compositions containing same |
US10544204B2 (en) | 2000-03-07 | 2020-01-28 | Firmenich Incorporated | TIR taste receptors and genes encoding same |
US7524637B2 (en) | 2000-03-07 | 2009-04-28 | Senomyx, Inc. | Functional assays that use the T1R1 receptor to screen for T1R1-associated taste modulators |
US7781181B2 (en) | 2001-01-03 | 2010-08-24 | Senomyx, Inc. | Human T1R2 polypeptide functional assays |
US8153774B2 (en) | 2001-01-03 | 2012-04-10 | Senomyx, Inc. | Human T1R2 taste receptor nucleic acids and cells containing these nucleic acids |
US7435552B2 (en) | 2001-01-03 | 2008-10-14 | Senomyx, Inc | Binding assays that use human T1R2 to identify potential taste modulators |
US8067539B2 (en) | 2001-01-03 | 2011-11-29 | Senomyx, Inc. | T1R taste receptors and genes encoding same |
US8450457B2 (en) | 2001-01-03 | 2013-05-28 | Senomyx, Inc. | T1R taste receptors and genes encoding same |
US7786263B2 (en) | 2001-01-03 | 2010-08-31 | Senomyx, Inc. | Human T1R2 taste receptor polypeptides |
US9790265B2 (en) | 2001-01-03 | 2017-10-17 | Senomyx, Inc. | T1R taste receptors and genes encoding same |
US8361729B2 (en) | 2001-01-03 | 2013-01-29 | Senomyx, Inc. | Detection of cells expressing T1R2 taste receptor |
US8138322B2 (en) | 2001-01-03 | 2012-03-20 | Senomyx, Inc. | Human T1R2 nucleic acid sequences and polypeptides |
US7534577B2 (en) | 2001-01-03 | 2009-05-19 | Senomyx, Inc. | Functional assays that use the T1R2 taste receptor to identify potential taste modulators |
US7655422B2 (en) | 2001-01-03 | 2010-02-02 | Senomyx, Inc. | T1R2 binding assays |
US10597437B2 (en) | 2001-01-03 | 2020-03-24 | Firmenich Incorporated | T1R taste receptors and genes encoding same |
US7588916B2 (en) | 2001-01-03 | 2009-09-15 | Senomyx, Inc. | T1R taste receptors and genes encoding same |
US10114009B2 (en) | 2001-03-07 | 2018-10-30 | Senomyx, Inc. | Methods of detecting T1R hetero-oligomeric taste receptor expression to identify cells that are potentially sensitive to sweet tastants |
US9671390B2 (en) | 2001-03-07 | 2017-06-06 | Senomyx, Inc. | In vitro method using hetero-oligomeric T1R1/T1R3 taste receptors to identify umami tastants |
US8153763B2 (en) | 2001-03-07 | 2012-04-10 | Senomyx, Inc. | Heteromeric T1R2/T1R3 taste receptors |
US7927825B2 (en) | 2001-03-07 | 2011-04-19 | Senomyx, Inc. | Methods of using T1R2/T1R3 heteromeric receptors to quantify taste of compounds for food or beverages |
US8173373B2 (en) | 2001-03-07 | 2012-05-08 | Senomyx, Inc. | Methods of screening T1R1/T1R3 heteromeric receptors for compounds that modulate umami taste signaling |
US7297543B2 (en) | 2001-03-07 | 2007-11-20 | Senomyx, Inc. | Cell lines that stably or transiently express a functional sweet (T1R2/T1R3) taste receptor |
US8039590B2 (en) | 2001-03-07 | 2011-10-18 | Senomyx, Inc. | Heteromeric taste receptors comprising T1R2/T1R3 domains |
US7368285B2 (en) | 2001-03-07 | 2008-05-06 | Senomyx, Inc. | Heteromeric umami T1R1/T1R3 taste receptors and isolated cells that express same |
US7763431B1 (en) | 2001-03-07 | 2010-07-27 | Senomyx, Inc. | Binding assays that use the T1R2/T1R3 (sweet) taste receptor to identify compounds that elicit or modulate sweet taste |
US7364903B2 (en) | 2001-03-07 | 2008-04-29 | Senomyx, Inc. | Cell lines that stably or transiently express a functional umami (T1R1/T1R3) taste receptor |
US8119402B2 (en) | 2001-03-07 | 2012-02-21 | Senomyx, Inc. | Methods of inhibiting T1R1/T1R3 heteromeric umami taste receptors |
US7601513B2 (en) | 2001-03-07 | 2009-10-13 | Senomyx, Inc. | Recombinant methods for expressing a functional umami (T1R1/T1R3) taste receptor |
US7344859B2 (en) | 2001-03-07 | 2008-03-18 | Senomyx, Inc. | Recombinant methods for expressing a functional sweet (T1R2/T1R3) taste receptor |
US10670584B2 (en) | 2001-03-07 | 2020-06-02 | Firmenich Incorporated | In vitro methods of detecting heteroligomeric T1R2/T2R3-expressing cells that are potentially sensitive to sweet tastants |
US7309577B2 (en) | 2001-03-07 | 2007-12-18 | Senomyx, Inc. | Binding assays that use the T1R1/T1R3 (umami) taste receptor to identify compounds that elicit or modulate umami taste |
US8097426B2 (en) | 2001-03-07 | 2012-01-17 | Senomyx, Inc. | Methods of screening T1R2/T1R3 receptors for compounds which modulate sweet taste signaling |
US8071719B2 (en) | 2001-03-07 | 2011-12-06 | Senomyx, Inc | Heteromeric taste receptors |
US7910322B2 (en) | 2001-03-07 | 2011-03-22 | Senomyx, Inc. | Methods for identifying compounds that modulate T1R1/T1R3 umami taste receptors |
US7906328B2 (en) | 2001-03-07 | 2011-03-15 | Senomyx, Inc. | Cell lines that express hetero oligomeric taste receptors |
US8067185B2 (en) | 2001-03-07 | 2011-11-29 | Senomyx, Inc. | Methods of quantifying taste of compounds for food or beverages |
US7892765B2 (en) | 2001-04-19 | 2011-02-22 | Senomyx, Inc. | Methods of screening modulators of hetero-oligomeric sweet taste receptors |
US7419791B2 (en) | 2001-04-19 | 2008-09-02 | Senomyx, Inc. | Methods of screening compounds using a T1R3 hetero-oligomeric taste receptor |
US10591464B2 (en) | 2001-04-19 | 2020-03-17 | Firmenich Incorporated | Methods of using T1R hetero-oligomeric taste receptors to screen for compounds which modulate sweet or umami taste signaling |
US10088472B2 (en) | 2001-04-19 | 2018-10-02 | Senomyx, Inc. | Methods of using TIR hetero-oligomeric receptors for screening compounds that modulate sweet or umami taste |
US20100009385A1 (en) * | 2001-05-01 | 2010-01-14 | Bryan Moyer | Assays and enhancers of the human delta enac sodium channel |
US10078087B2 (en) * | 2001-05-01 | 2018-09-18 | Senomyx, Inc. | Assays and enhancers of the human delta ENaC sodium channel |
US10215759B2 (en) | 2001-05-01 | 2019-02-26 | Senomyx, Inc. | Electrophysiological assays using oocytes that express human ENaC and the use of phenamil to improve the effect of ENaC enhancers in assays using membrane potential reporting dyes |
US7301009B2 (en) | 2001-06-26 | 2007-11-27 | Senomyx, Inc. | Isolated (T1R1/T1R3) umami taste receptors that respond to umami taste stimuli |
US7294474B2 (en) | 2001-06-26 | 2007-11-13 | Senomyx, Inc. | Functional assays for identifying compounds that modulate T1R2/T1R3 (sweet) taste |
US7303886B2 (en) | 2001-06-26 | 2007-12-04 | Senumyx, Inc. | Functional assays for identifying compounds that modulate T1R1/T1R3 (umami) taste |
US7297772B2 (en) | 2001-06-26 | 2007-11-20 | Senomyx, Inc. | Isolated (T1R2/T1R3) sweet taste receptors that respond to sweet taste stimuli |
US10048274B2 (en) | 2003-07-10 | 2018-08-14 | Senomyx Inc. | Electrophysiological assays using oocytes that express human ENaC and the use of phenamil to improve the effect of ENaC enhancers in assays using membrane potential reporting dyes |
US8247184B2 (en) | 2003-08-06 | 2012-08-21 | Senomyx, Inc. | Assays using chimeric T1R polypeptides for identifying putative taste modulatory compounds |
US11268952B2 (en) | 2003-08-06 | 2022-03-08 | Firmenich Incorporated | Flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof |
US8124121B2 (en) | 2003-08-06 | 2012-02-28 | Senomyx, Inc. | Flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof |
US7476399B2 (en) | 2003-08-06 | 2009-01-13 | Senomyx Inc. | Flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof |
US7906627B2 (en) | 2003-08-06 | 2011-03-15 | Senomyx, Inc. | Chimeric human sweet-umami and umami-sweet taste receptors |
US10557845B2 (en) | 2003-08-06 | 2020-02-11 | Firmenich Incorporated | Flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof |
US10060909B2 (en) | 2003-08-06 | 2018-08-28 | Senomyx, Inc. | Flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof |
USRE44339E1 (en) | 2003-11-21 | 2013-07-02 | Givaudan S.A. | N-substituted P-menthane carboxamides |
US8784782B2 (en) | 2005-02-04 | 2014-07-22 | Senomyx, Inc. | Compounds comprising linked heteroaryl moieties and their use as novel umami flavor modifiers, tastants and taste enhancers for comestible compositions |
JP2008530020A (en) * | 2005-02-04 | 2008-08-07 | セノミックス インコーポレイテッド | Aromatic amides and ureas, and sweetness and / or umami modifiers, umami and / or sweeteners and their use as umami enhancers and / or sweet taste improvers |
US8968708B2 (en) | 2005-02-04 | 2015-03-03 | Senomyx, Inc. | Compounds comprising linked heteroaryl moieties and their use as novel umami flavor modifiers, tastants and taste enhancers for comestible compositions |
WO2006099762A1 (en) * | 2005-03-24 | 2006-09-28 | Givaudan Sa | Cooling compounds |
JP2008543313A (en) * | 2005-06-15 | 2008-12-04 | セノミックス インコーポレイテッド | Diaromatic amides and their use as flavoring and flavoring or flavor enhancers |
US7842324B2 (en) | 2005-06-15 | 2010-11-30 | Senomyx, Inc. | Bis-aromatic amides and their uses as sweet flavor modifiers, tastants, and taste enhancers |
AU2006304797B2 (en) * | 2005-10-20 | 2013-01-31 | Senomyx, Inc. | Chimeric human sweet-umami and umami-sweet taste receptors |
WO2007047988A3 (en) * | 2005-10-20 | 2009-04-23 | Senomyx Inc | Chimeric human sweet-umami and umami-sweet taste receptors |
EP1937718A2 (en) * | 2005-10-20 | 2008-07-02 | Senomyx, Inc. | Chimeric human sweet-umami and umami-sweet taste receptors |
EP3312194A1 (en) * | 2005-10-20 | 2018-04-25 | Senomyx, Inc. | Cell lines expressing chimeric human sweet-umami and umami-sweet taste receptors |
WO2007047988A2 (en) | 2005-10-20 | 2007-04-26 | Senomyx, Inc. | Chimeric human sweet-umami and umami-sweet taste receptors |
EP1937718A4 (en) * | 2005-10-20 | 2009-11-11 | Senomyx Inc | Chimeric human sweet-umami and umami-sweet taste receptors |
JP2009517003A (en) * | 2005-10-20 | 2009-04-30 | セノミクス・インコーポレーテッド | Chimeric human sweetness-umami and umami-sweet taste receptors |
CN101605810B (en) * | 2005-10-20 | 2013-07-17 | 塞诺米克斯公司 | Chimeric human sweet-umami and umami-sweet taste receptors |
JP2017192386A (en) * | 2006-04-20 | 2017-10-26 | ジボダン エス エー | Method relating sweetness enhancement |
WO2007121599A1 (en) | 2006-04-20 | 2007-11-01 | Givaudan Sa | Functional method to identify tastants |
EP2995950A1 (en) * | 2006-04-20 | 2016-03-16 | Givaudan SA | Method relating to sweetness enhancement |
US8124360B2 (en) | 2006-04-20 | 2012-02-28 | Givaudan S.A. | Use of a T1R2 nucleic acid sequence to identify tastants |
JP2015091242A (en) * | 2006-04-20 | 2015-05-14 | ジボダン エス エー | Method for enhancing sweetness |
US9072313B2 (en) | 2006-04-21 | 2015-07-07 | Senomyx, Inc. | Comestible compositions comprising high potency savory flavorants, and processes for producing them |
US7964376B2 (en) | 2006-06-19 | 2011-06-21 | Givaudan Sa | Chimeric proteins and their use in methods to screen for sweet taste modulators |
WO2007147275A1 (en) * | 2006-06-19 | 2007-12-27 | Givaudan Sa | Nucleic acid, polypeptide and its use |
KR101440639B1 (en) * | 2006-06-19 | 2014-09-22 | 지보당 에스아 | Nucleic acid, polypeptide and its use |
JP2009540804A (en) * | 2006-06-19 | 2009-11-26 | ジボダン エス エー | Nucleic acids, polypeptides and uses thereof |
US9244081B2 (en) * | 2006-07-28 | 2016-01-26 | Senomyx, Inc. | Cell-based fluorescent assays for identifying alpha and delta ENaC modulators |
US20090181404A1 (en) * | 2006-07-28 | 2009-07-16 | Guy Servant | Cell-based fluorescent assays for identifying alpha and delta EnaC modulators |
WO2008086634A3 (en) * | 2007-01-18 | 2008-09-04 | Givaudan Sa | Chimeric umami taste receptor, nucleic acid encoding it and use thereof |
JP2010516232A (en) * | 2007-01-18 | 2010-05-20 | ジボダン エス エー | Chimeric umami receptor, nucleic acid encoding it, and use thereof |
US8039233B2 (en) | 2007-01-18 | 2011-10-18 | Givaudan S.A. | Nucleic acid sequences and their use in methods to identify umami modulatiors |
WO2008086634A2 (en) * | 2007-01-18 | 2008-07-24 | Givaudan Sa | Chimeric umami taste receptor, nucleic acid encoding it and use thereof |
AU2017200704B2 (en) * | 2007-06-08 | 2019-10-31 | Firmenich Incorporated | Modulation of chemosensory receptors and ligands associated therewith |
US9603848B2 (en) | 2007-06-08 | 2017-03-28 | Senomyx, Inc. | Modulation of chemosensory receptors and ligands associated therewith |
EP2568287A2 (en) * | 2007-06-08 | 2013-03-13 | Senomyx, Inc. | Modulation of chemosensory receptors and ligands associated |
US9181276B2 (en) | 2007-06-08 | 2015-11-10 | Senomyx, Inc. | Modulation of chemosensory receptors and ligands associated therewith |
EP2568287A3 (en) * | 2007-06-08 | 2013-07-17 | Senomyx, Inc. | Modulation of chemosensory receptors and ligands associated |
WO2009111447A2 (en) | 2008-03-03 | 2009-09-11 | Senomyx, Inc. | Isosorbide derivatives and their use as flavor modifiers, tastants, and taste enhancers |
US10308621B2 (en) | 2008-07-31 | 2019-06-04 | Senomyx, Inc. | Processes and intermediates for making sweet taste enhancers |
US9732052B2 (en) | 2008-07-31 | 2017-08-15 | Senomyx, Inc. | Processes and intermediates for making sweet taste enhancers |
US10087154B2 (en) | 2008-07-31 | 2018-10-02 | Senomyx, Inc. | Processes and intermediates for making sweet taste enhancers |
US10570105B2 (en) | 2008-07-31 | 2020-02-25 | Firmenich Incorporated | Processes and intermediates for making sweet taste enhancers |
WO2011039340A2 (en) | 2009-10-02 | 2011-04-07 | Givaudan Sa | Flavour enhancement |
EP2520647A4 (en) * | 2009-12-02 | 2013-07-10 | Hasegawa T Co Ltd | Sweet taste receptor expression construct, cell body expressing same, and uses therefor |
US8658383B2 (en) | 2009-12-02 | 2014-02-25 | T. Hasegawa Co., Ltd. | Sweet taste receptor-expressing construct, cell body expressing the same, and utilization thereof |
EP2520647A1 (en) * | 2009-12-02 | 2012-11-07 | T. Hasegawa Co., Ltd. | Sweet taste receptor expression construct, cell body expressing same, and uses therefor |
US8470384B2 (en) | 2010-02-04 | 2013-06-25 | Givaudan S.A. | Oxalamide derivative as umami flavouring agent |
WO2011095533A1 (en) | 2010-02-04 | 2011-08-11 | Givaudan Sa | Oxalamide derivative as umami flavouring agent |
US9834544B2 (en) | 2010-04-02 | 2017-12-05 | Senomyx, Inc. | Sweet flavor modifier |
US9049878B2 (en) | 2010-04-02 | 2015-06-09 | Senomyx, Inc. | Sweet flavor modifier |
US9902737B2 (en) | 2010-04-02 | 2018-02-27 | Senomyx, Inc. | Sweet flavor modifier |
WO2012054530A3 (en) * | 2010-10-19 | 2013-10-31 | Elcelyx Therapeutics, Inc. | Chemosensory receptor ligand-based therapies |
US20120122842A1 (en) * | 2010-11-15 | 2012-05-17 | Abbott Laboratories | Nampt and rock inhibitors |
US9302989B2 (en) * | 2010-11-15 | 2016-04-05 | Abbvie Inc. | NAMPT and rock inhibitors |
US10093624B2 (en) | 2010-11-15 | 2018-10-09 | Abbvie Inc. | NAMPT and ROCK inhibitors |
US10299999B2 (en) | 2011-02-23 | 2019-05-28 | Givaudan S.A. | Flavour composition comprising menthol and menthane carboxamides |
WO2013060816A1 (en) | 2011-10-26 | 2013-05-02 | Givaudan Sa | Organic compounds |
WO2013060812A2 (en) | 2011-10-26 | 2013-05-02 | Givaudan Sa | Organic compounds |
WO2013060815A1 (en) | 2011-10-26 | 2013-05-02 | Givaudan Sa | Organic compounds |
WO2013060814A2 (en) | 2011-10-26 | 2013-05-02 | Givaudan Sa | Organic compounds |
WO2013060813A1 (en) | 2011-10-26 | 2013-05-02 | Givaudan Sa | Organic compounds |
US9687015B2 (en) | 2012-08-06 | 2017-06-27 | Senomyx, Inc. | Sweet flavor modifier |
US9745293B2 (en) | 2012-08-06 | 2017-08-29 | Senomyx, Inc. | Sweet flavor modifier |
US8877922B2 (en) | 2012-08-06 | 2014-11-04 | Senomyx, Inc. | Sweet flavor modifier |
US9138013B2 (en) | 2012-08-06 | 2015-09-22 | Senomyx, Inc. | Sweet flavor modifier |
US9695162B2 (en) | 2013-02-19 | 2017-07-04 | Senomyx, Inc. | Sweet flavor modifier |
US9000151B2 (en) | 2013-02-19 | 2015-04-07 | Senomyx, Inc. | Sweet flavor modifier |
US9804157B1 (en) | 2013-03-15 | 2017-10-31 | Senomyx, Inc. | Screening assays to identify compounds which modulate T1R associated taste modalities which eliminate false positives |
US10281467B2 (en) | 2013-03-15 | 2019-05-07 | Senomyx, Inc. | Screening assays to identify compounds which modulate T1R associated taste modalities which eliminate false positives |
WO2015000900A2 (en) | 2013-07-01 | 2015-01-08 | Givaudan Sa | Organic compounds |
US10178875B2 (en) | 2013-07-01 | 2019-01-15 | Givaudan S.A. | Methods of modifying or imparting taste using organic compounds |
US10226062B2 (en) | 2013-12-05 | 2019-03-12 | Givaudan Sa | Organic compounds |
EP2924050A1 (en) * | 2014-03-28 | 2015-09-30 | Ajinomoto Co., Inc. | Sweet taste receptor chimeric proteins and use thereof |
US9341616B2 (en) | 2014-03-28 | 2016-05-17 | Ajinomoto Co., Inc. | Sweet taste receptor chimeric proteins and use thereof |
US11339128B2 (en) | 2014-11-07 | 2022-05-24 | Firmenich Incorporated | Substituted 4-amino-5-(cyclohexyloxy)quinoline-3-carboxylic acids as sweet flavor modifiers |
WO2016118882A1 (en) * | 2015-01-23 | 2016-07-28 | cP2 SCIENCE, INC. | Fragrance and flavor compositions comprising neopentyl glycol diacetate |
US10072233B2 (en) | 2015-01-23 | 2018-09-11 | P2 Science, Inc. | Fragrance and flavor compositions comprising neopentyl glycol diacetate |
US11758933B2 (en) | 2015-10-29 | 2023-09-19 | Firmenich Incorporated | High intensity sweeteners |
US11357246B2 (en) | 2015-10-29 | 2022-06-14 | Firmenich Incorporated | High intensity sweeteners |
CN106620144A (en) * | 2016-12-29 | 2017-05-10 | 姜富春 | Traditional Chinese medicine preparation for treating chronic pelvic inflammation and preparation method thereof |
US11060124B2 (en) | 2017-05-03 | 2021-07-13 | Firmenich Incorporated | Methods for making high intensity sweeteners |
US11945813B2 (en) | 2018-08-07 | 2024-04-02 | Firmenich Incorporated | 5-substituted 4-amino-1H-benzo[c][1,2,6]thiadiazine 2,2-dioxides and formulations and uses thereof |
CN114375163A (en) * | 2019-06-12 | 2022-04-19 | 玉米产品开发公司 | Compositions with sugar-like characteristics |
WO2020251928A1 (en) * | 2019-06-12 | 2020-12-17 | Corn Products Development, Inc. | Compositions with sugar like characteristics |
WO2021063942A1 (en) | 2019-09-30 | 2021-04-08 | Givaudan Sa | Improvements in or relating to organic compounds |
WO2021175751A1 (en) * | 2020-03-05 | 2021-09-10 | Firmenich Sa | 11-oxo-cucurbitanes and their use as flavor modifiers |
WO2023091315A3 (en) * | 2021-11-16 | 2023-07-20 | Firmenich Incorporated | Amide compounds and their use as flavor modifiers |
WO2023154597A1 (en) * | 2022-02-11 | 2023-08-17 | Firmenich Incorporated | Cells expressing umami taste receptors and uses thereof |
WO2023172372A1 (en) * | 2022-03-11 | 2023-09-14 | Firmenich Incorporated | Amide compounds and their use as flavor modifiers |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20200049699A1 (en) | T1r hetero-oligomeric taste receptors, cell lines that express said receptors, and taste compounds | |
US10114009B2 (en) | Methods of detecting T1R hetero-oligomeric taste receptor expression to identify cells that are potentially sensitive to sweet tastants | |
EP1412750B1 (en) | T1r2-t1r3 hetero-oligomeric sweet taste receptors and cell lines that express said receptors and use thereof for identification of sweet taste compounds | |
US7301009B2 (en) | Isolated (T1R1/T1R3) umami taste receptors that respond to umami taste stimuli | |
JP2007512227A5 (en) | ||
CA2827128C (en) | T1r hetero-oligomeric taste receptors, cell lines that express said receptors, and taste compounds | |
AU2011236059A1 (en) | T1R hetero-oligomeric taste receptors, cell lines that express said receptors, and taste compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200480022612.5 Country of ref document: CN |
|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
COP | Corrected version of pamphlet |
Free format text: PAGES 1/27-27/27, DRAWINGS, REPLACED BY NEW PAGES 1/40-40/40 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2535045 Country of ref document: CA Ref document number: 173552 Country of ref document: IL Ref document number: 12006500281 Country of ref document: PH Ref document number: 2006522754 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/2006/001510 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007104709 Country of ref document: US Ref document number: 10569870 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004780314 Country of ref document: EP Ref document number: 2006/01903 Country of ref document: ZA Ref document number: 545747 Country of ref document: NZ Ref document number: 06022158 Country of ref document: CO Ref document number: 1194/DELNP/2006 Country of ref document: IN Ref document number: 1200600343 Country of ref document: VN Ref document number: 2004263871 Country of ref document: AU Ref document number: 2006106920 Country of ref document: RU Ref document number: 200601903 Country of ref document: ZA |
|
ENP | Entry into the national phase |
Ref document number: 2004263871 Country of ref document: AU Date of ref document: 20040806 Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 2004263871 Country of ref document: AU |
|
WWP | Wipo information: published in national office |
Ref document number: 2004780314 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: PI0413324 Country of ref document: BR |
|
WWP | Wipo information: published in national office |
Ref document number: 10569870 Country of ref document: US |